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Oskar (Osk) is a posterior body-patterning determinant in Drosophila 
melanogaster and is highly concentrated at the posterior pole of the oocyte. osk 
mRNA is translationally repressed until it reaches the posterior of the oocyte 
where Osk protein is made. Bruno (Bru) represses translation during osk mRNA 
localization by direct binding, but how Bru-mediated repression is relieved at the 
posterior of the oocyte is unknown. Two types of Bru protein interactions are 
implicated in repression of osk: Bru-Cup interaction and Bru dimerization. By 
mapping the Bru domains that are important for these interactions, I found that 
the amino-terminal domain of Bru contributes to both interactions, and deletion of 
this domain caused a defect in translational repression. However point mutations, 
within the amino-terminal domain, that disrupt both types of interaction in vitro did 
not interfere with translational repression in vivo. The difference may be due to 
other factors stabilizing the Bru-Cup interaction in vivo, as the mutant Bru still 
associates with Cup in vivo. My work supports the model of repression that relies 
on Bru interaction with Cup. I also build a new model in which Bru dimerization 
promotes translational activation of osk, based on my unexpected results: 
 vii 
dimerization-defective Bru only weakly accumulated Osk::GFP fusion protein 
encoded by an osk::GFP reporter RNA bearing a Bru-binding region, while 
dimerization-competent Bru showed the opposite effect. This suggests that 
dimerization may contribute to switching Bru from a repressor to an activator, 
with dimerization controlled via a post-translational modification. Consistent with 
this, I found that a small fraction of Bru in ovaries is phosphorylated. PKA is a 
positive regulator of osk expression and phosphorylates Bru in vitro. To test if 
PKA regulation of osk is mediated through Bru, I examined the effect of altering 
PKA activity on Bru phosphorylation and Bru-mediated repression. Modulating 
PKA activity caused small, yet detectable changes in Bru phosphorylation and 
Bru-dependent translational repression using an osk::GFP reporter. However, 
while the studies with Bru mutants suggest that phosphorylation promotes 
repression by Bru, these studies argue for a role in promoting activation. Further 
work will be required to explain these phenomena.  
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Chapter 1: General Introduction 
AXIAL PATTERNING IN EARLY DROSOPHILA DEVELOPMENT 
Establishment and maintenance of cell polarity can be achieved by 
asymmetric accumulation of proteins to distinct subcellular compartments. Both 
mRNA localization and regulated translation during transport are mechanisms 
used to restrict gene expression in space and time. Embryonic axis formation in 
many vertebrate and invertebrate organisms is often achieved by actions of 
maternal RNA determinants that are localized to distinct compartments within 
eggs or oocytes (Kumano, 2011; Medioni et al., 2012).  
In Drosophila, localized RNAs specify patterning along both 
anteroposterior and dorsoventral axes (Fig 1.1). The first axis to be specified is 
the anteroposterior axis, which is first established by localization of the gurken 
(grk) mRNA to the posterior pole of the oocyte during early oogenesis (González-
Reyes et al., 1995; Roth et al., 1995). The grk mRNA encodes a transforming 
growth factor (TGF)-α homologue. Upon Grk signaling-dependent microtubule 
rearrangement, localization of the bicoid (bcd) mRNA to the anterior (Berleth et 
al., 1988) and the oskar (osk) and nanos (nos) mRNAs to the posterior (Ephrussi 
et al., 1991; Kim-Ha et al., 1991; Gavis and Lehmann, 1992) of the oocyte 
establish the anteroposterior axis. The bcd and nos mRNAs are translationally 
repressed in late-stage oocytes, and this repression is relieved upon fertilization. 
Bcd and Nos proteins are produced in opposing gradients in embryos to direct 
formation of head and thorax (Bcd; Driever and Nüsslein-Volhard, 1988), and 
abdomen (Nos; Lehmann and Nüsslein-Volhard, 1991). Following specification of 
the anteroposterior axis, the grk mRNA moves to the anterodorsal corner of the 
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growing oocyte to specify the dorsoventral axis (Neuman-Silberberg and 
Schüpbach, 1993).  
The osk mRNA is translated at the posterior pole of the oocyte during mid 
oogenesis to initiate assembly of the germ/pole plasm, a specialized cytoplasm 
containing RNAs and proteins required for abdominal patterning and germ/pole 
cell formation (Ephrussi and Lehmann, 1992; Kim-Ha et al., 1995; Markussen et 
al., 1995). Embryos lacking maternal Osk activity fail to form both abdomen and 
germ cells (Lehmann and Nüsslein-Volhard, 1986). Moreover, overexpression or 
misexpression of Osk at the anterior leads to ectopic abdomen and germ cells 
(Ephrussi and Lehmann, 1992; Smith et al., 1992). Thus osk must be tightly 
regulated for the viability of the embryo.  
The dorsoventral axis is established by a signaling pathway mediated by 
uniformly distributed Toll receptors, which are activated only on the ventral side 
of the embryo by a ventrally restricted serine protease cascade (Roth, 1994; 
Stein, 1995). Grk signaling in the anterodorsal corner of the oocyte restricts the 
expression of the pipe mRNA to the ventral cells of the follicular epithelium that 
surrounds the oocyte (Sen et al. 1998). Pipe generates a ventral cue that locally 
activates the serine protease cascade to generate the active ligand for Toll 
(Zhang et al., 2009; Cho et al., 2010).  
 
DROSOPHILA OOGENESIS 
Oogenesis is development of the egg in female ovaries and is arbitrarily 
divided into 14 morphologically distinct stages in Drosophila (Fig 1.2; Spradling et 
al., 1993). The egg chamber is the functional unit of oogenesis and is produced 
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in the germarium containing germline and somatic stem cells. At the anterior tip 
of the germarium, the germline stem cell divides to give a new stem cell and a 
cystoblast. Cystoblasts in turn divide four times, with incomplete cytokinesis, to 
give rise to a cyst of 16 cells that are interconnected by cytoplasmic bridges 
called ring canals. The nurse cells produce macromolecules and organelles, 
which are transported to the developing oocyte through the ring canals to aid 
oocyte maturation, while the oocyte nucleus remains largely quiescent (Spradling 
et al., 1993; de Cuevas et al., 1997). Toward the end of oogenesis, the nurse 
cells degenerate and expel their bulk cytoplasm into the oocyte (“nurse cell 
dumping”). The 16-cell cyst is surrounded by a single, epithelial layer of somatic 
follicle cells, which secrete the eggshell and play crucial roles in signaling 
pathways that underlie oocyte polarity. The egg chambers mature in an ovariole, 
in which progressively later stages of egg chambers are found toward the 
posterior. A female Drosophila has two ovaries, each of which holds 
approximately 18 ovarioles (Riechmann and Ephrussi, 2001; Bastock and St. 
Johnston, 2008).  
 Maternal RNAs and proteins are stored in the oocyte to govern early 
embryonic development (Davidson, 1986). They are transported from the nurse 
cells to the oocyte in a microtubule-dependent manner (Pokrywka and 
Stephenson, 1995), but almost all components of the cytoplasm are also 
transported by a microfilament-dependent process during nurse cell dumping. 
Asymmetric distribution of several maternal RNAs in the oocyte depends on 
microtubules. (Riechmann and Ephrussi, 2001; Kugler and Lasko, 2009, Gaspar, 
2011).  
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MRNA LOCALIZATION COUPLED WITH TRANSLATIONAL REGULATION 
mRNA localization and translational regulation are two mechanisms to 
achieve asymmetric protein accumulation in polarized cells. These processes 
occur in situations that require spatial and temporal regulation of gene 
expression, such as asymmetric cell division, cell fate specification, cell motility, 
embryonic axis formation, and synaptic plasticity (Johnstone and Lasko, 2001; 
Condeelis and Singer, 2005; King et al., 2005; Martin and Zukin, 2006; Paquin 
and Chartrand, 2008). The two processes are generally thought to be coupled by 
assembling ribonucleoprotein (RNP) complexes containing RNAs and associated 
trans-acting factors that function in localization and/or translational regulation. 
Transport RNP complexes are usually considered to form co-transcriptionally and 
undergo dynamic remodeling during transport by numerous protein 
rearrangements, to dictate the fate of the RNP at each step of its maturation 
(Lewis and Mowry, 2007; Besse and Ephrussi, 2008). RNPs form by binding of 
trans-acting factors (proteins, as well as miRNAs) to cis-regulatory elements in 
RNAs. RNP complexes engage with motors for directed transport along 
microtubules and microfilaments. Localizing RNAs are often translationally 
silenced, and their translation is derepressed upon localization or activated in 
response to a specific signal (Besse and Ephrussi, 2008; Medioni et al., 2012).   
The osk mRNA is transcribed from the nurse cell nuclei, and many trans-
acting factors involved in localization and/or translational repression of osk are 
nucleo-cytoplasmic shuttling proteins that may first bind osk RNA in the nurse cell 
nuclei (Kugler and Lasko, 2009; Kato and Nakamura, 2012). Following pre-
mRNA processing events, the osk mRNA is exported into the nurse cell 
cytoplasm. In a process dependent on microtubules (Pokrywka and Stephenson, 
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1995), the osk mRNA is transported into the oocyte through the ring canals at 
stage 1 of oogenesis and remains highly concentrated in the oocyte. After 
transient concentration at the oocyte anterior at stage 8, osk message gets tightly 
localized to the posterior of the oocyte by stage 9 and remains localized until 
early embryogenesis (Ephrussi et al., 1991; Kim-Ha et al., 1991). The osk mRNA 
is translated only after it is localized to the posterior pole (Kim-Ha et al., 1995; 
Markussen et al., 1995; Rongo et al., 1995). Usage of alternative start codons 
that are in the same reading frame within the coding sequence makes two Osk 
isoforms, which have distinct functions (Fig 1.3; Markussen et al., 1995). The 
Long Osk is required for anchoring of the osk mRNA and short Osk protein. The 
Short Osk induces formation of germ plasm containing determinants for both 
posterior patterning and germ cell formation (Markussen et al., 1995; Vanzo and 
Ephrussi, 2002).  
A large number of trans-acting factors that regulate different steps in 
localization and translational regulation of osk have been identified. Some of 
these factors are involved in both localization and translational control, while 
others involved in only one process nevertheless interact with each other, 
indicative of coupling of the two processes (Kugler and Lasko, 2009; Kato and 
Nakamura, 2012). Mechanisms of osk localization and translation have been 
extensively studied, but many aspects of post-transcriptional regulation of osk still 
remain to be elucidated.   
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OSKAR MRNA TRANSPORT 
The osk mRNA transport to the posterior of the oocyte requires 
microtubules (Pokrywka and Stephenson, 1995). Prior to stage 7, a microtubule-
organizing center (MTOC) at the oocyteʼs presumptive posterior nucleates 
microtubules, which extend to the nurse cells through the ring canals (Theurkauf 
et al., 1993). After Grk signaling to the posterior follicle cells at stage 7, the 
microtubule network undergoes a drastic rearrangement. The MTOC at the 
posterior disassembles, and microtubules are nucleated from anterior and lateral 
cortices. This creates a decreasing gradient of microtubules from anterior to 
posterior, with plus ends enriched at the posterior (Theurkauf et al., 1992; 
González-Reyes et al., 1995; Roth et al., 1995; Cha et al., 2002).  
Motor proteins move along microtubules toward either a minus end or plus 
end. The minus-end-directed microtubule motor, Dynein, is required for osk 
transport into the oocyte but dispensable for posterior localization (Januschke et 
al., 2002). Kinesin is the plus-end-directed microtubule motor. Kinesin heavy 
chain (KHC) is the force-producing subunit of the tetrameric Kinesin I, the 
conventional kinesin (Martin et al., 1999). In the khc27 mutant, the osk mRNA is 
transported to the oocyte, but not localized to the posterior (Brendza et al., 2000). 
From the combined data, osk seems to switch from Dynein motor in nurse cells, 
to Kinesin I in oocyte.  
Live imaging of the osk mRNA in the oocyte further supports this model. 
An osk mRNA bearing bacteriophage MS2 sites was constructed. The osk-MS2 
RNA was expressed in flies that also express MS2-nls-GFP fusion protein, which 
tethers to MS2 sites and displays the characteristic osk mRNA localization 
pattern (Zimyanin et al., 2008). GFP/osk-MS2 particles move fast in all directions 
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at stage 9, with a small posterior bias due to plus-end-directed movement along 
weakly polarized microtubules. Consistent with Kinesin-dependent posterior 
transport, there was a great reduction in fast, directed movement seen in khc 
mutants, but no effect seen in dynein heavy chain (dhc) mutants (Zimyanin et al., 
2008).  
Microtubule motor proteins interact with adaptor proteins that recruit 
cargoes for directed transport. A candidate protein complex that could link 
mRNAs to motors is the Exon Junction Complex (EJC). The EJC is a multi-
protein complex that binds the mRNA upstream of exon-exon junctions 
concomitant with splicing, and is thought to remain bound to the mRNA until the 
first round of translation (Tange et al., 2005). The core protein components of the 
Drosophila EJC are eIF4AIII, Barentz, Mago Nashi, and Y14/Tsunagi, which are 
all required for osk localization to the posterior (van Eeden et al., 2001; Hachet 
and Ephrussi, 2001; Mohr et al., 2001; Palacios et al., 2004). Consistent with the 
requirement for splicing in EJC deposition, posterior localization of the osk 
transcript was shown to depend on the presence of the first intron (Hachet and 
Ephrussi, 2004), in addition to the 3ʼ UTR (Kim-Ha et al., 1993). Splicing of the 
first intron, in turn, results in formation of a 28nt stem-loop structure termed 
SOLE (spliced oskar localization element), made by joining of the last 18nt of 
exon1 and first 10nt of exon2, and EJC loading. The structural, rather than 
sequence, integrity of the SOLE is required for efficient osk RNP motility for 
posterior localization (Ghosh et al., 2012). In summary, splicing in the nurse cell 
nucleus is required for correct localization of the osk mRNA in the oocyte 
cytoplasm, and the EJC components loaded upon splicing play a pivotal role in 
osk mRNA localization.  
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The osk 3ʼ UTR is also required for correct localization of osk, and 
different elements within the 1043nt 3ʼ UTR mediate distinct steps in localization 
(Kim-Ha et al., 1993). Many trans-acting factors are required for correct 
localization of osk, and some bind directly to the 3ʼ UTR. Hrp48 is a Drosophila 
hnRNP A/B homolog required for posterior localization of osk, which colocalizes 
with the osk transcript throughout oogenesis (Huynh et al., 2004; Yano et al., 
2004). Heterogeneous nuclear RNP (hnRNP) proteins are a family of RNA-
binding proteins involved in many aspects of RNA regulation, and many are 
nucleo-cytoplasmic shuttling proteins that first bind RNA in the nucleus (Dreyfuss 
et al., 2002). Therefore Hrp48 may bind osk in the nurse cell nuclei and remain 
associated until localization, similar to the EJC complex. Hrp48 directly binds osk 
3ʼ UTR, and three missense alleles disrupt posterior localization without affecting 
splicing or microtubule polarity (Huynh et al., 2004; Yano et al., 2004). 
Furthermore, formation of the osk-containing particles is disrupted in two of these 
missense mutants, implicating Hrp48 in osk RNP assembly (Huynh et al., 2004; 
Mhlanga et al., 2009).    
Staufen (Stau) is another protein that colocalizes with osk mRNA 
throughout oogenesis and is required for proper localization of osk and bcd 
mRNAs (St. Johnston et al., 1991). In stau mutants, osk mRNA is not properly 
localized at the posterior (Ephrussi et al., 1991; Kim-Ha et al., 1991), and no Osk 
protein is made (Kim-Ha et al., 1995; Markussen et al., 1995; Rongo et al., 1995). 
Stau has 5 double-stranded RNA (dsRNA)-binding domains, four of which bind 
dsRNA. Stau is thought to bind directly to osk mRNA, but biochemical proof has 
been difficult to obtain because of insolubility of the intact, full-length protein (St. 
Johnston et al., 1992; Micklem et al., 2000). Stau and osk are interdependent for 
 9 
their localization to the posterior pole (Ferrandon et al., 1994), most likely through 
interaction of Stau with the osk 3ʼ UTR, as the 3ʼ UTR is required for Stau 
transport into the oocyte (Jenny et al., 2006). A recent genome-wide analysis of 
the dsRNA-binding activity of Stau revealed that the 3ʼ UTRs of Stau-bound 
transcripts are highly enriched for three types of secondary structures, two of 
which are present within the osk 3ʼ UTR: Type II and III SRSs (Staufen-
recognized structures), which are motifs containing 19 (Type II) or 12 (Type III) 
contiguous bases that have 4 or 2 unpaired/mismatched bases at maximum, 
respectively. The osk 3ʼ UTR carries four Type II SRSs and one Type III SRS 
(Laver et al., 2013). Stau is also implicated in translational activation of osk, 
independent of its role in osk RNA localization (Kim-Ha et al., 1995; Micklem et 
al., 2000).  
After posterior localization, the osk mRNA is anchored at the posterior 
cortex (Ephrussi et al., 1991; Kim-Ha et al., 1991). Anchoring of the osk mRNA 
depends on the Long Osk protein, which also anchors the Short Osk protein; the 
Long-Osk-mediated anchoring is essential for efficient germ cell formation 
(Vanzo and Ephrussi, 2002). Anchoring of the osk mRNA also depends on the F-
actin cytoskeleton and a number of F-actin associated proteins (Polesello et al., 
2002; Babu et al., 2004; McNeil et al., 2009; Suyama et al., 2009). Consistent 
with this, Osk stimulates actin dynamics at the posterior pole. In osk protein-null 
mutants, cortical actin projections show decrease in number and length (Vanzo et 
al., 2007). Therefore, osk promotes its own localization in a positive feedback 
loop involving actin dynamics.  
Consistent with a role of actin cytoskeleton in osk anchoring, Myosin-V 
(Myo V) is required for posterior localization of osk. didum encodes the unique 
 10 
Drosophila class-V unconventional myosin, which is an actin-dependent motor 
(Bonafé and Sellers, 1998; MacIver et al., 1998). In didum mutants, the osk 
mRNA and Osk protein are not tightly anchored at the cortex (Krauss et al., 
2009). MyoV interacts with osk in vivo and may direct the final short-range 
actomyosin V-dependent translocation or entrapment, followed by a long-range 
microtubule-based transport. Interestingly, Myo V interacts with Khc in a yeast-
two-hybrid assay, and they genetically interact with each other in an antagonistic 
manner (Krauss et al., 2009). Therefore, coordination of microtubule- and actin-
based motors is essential for correct localization and anchoring of osk mRNA at 
the posterior pole.  
To summarize, transport of the osk mRNA from the nurse cells to the 
oocyte and localization to the posterior pole depend on the microtubule 
cytoskeleton and motors. The first intron and the 3ʼ UTR of osk are essential for 
correct localization, and many proteins bind directly or indirectly near/to these 
elements to mediate localization. Stau, Hrp48 and the EJC complex disrupt 
posterior localization without affecting oocyte transport. Other proteins that 
interact with the dynein-dynactin complex have been implicated in oocyte 
transport of the osk mRNA (Bullock and Ish-Horowicz, 2001; Dienstbier et al., 
2009). Therefore the osk RNP contains many trans-acting factors, of which each 
mediates a distinct step of localization; and it is plausible to think that the osk 
RNP undergoes remodeling during its lifetime, such as recruitment/displacement 
or post-translational modifications of factors to orchestrate a complicated 
localization process.  
 
 11 
TRANSLATIONAL REPRESSION OF OSKAR DURING TRANSPORT 
Only localized osk mRNA makes Osk protein, implicating that it is under 
translational regulation (Kim-Ha et al., 1995; Markussen et al., 1995; Rongo et 
al., 1995). Bruno (Bru; encoded by the arrest gene) was the first protein shown to 
directly bind and translationally repress osk RNA (Kim-Ha et al., 1995). Bru is a 
nucleo-cytoplasmic shuttling protein and may first bind osk in the nurse cell nuclei 
(Snee et al., 2008). Bru binds the osk 3ʼ UTR in two regions: AB close to the 
coding sequence and C close to the poly(A) tail (Fig 1.3). Each region contains 
multiple Bru-binding sites, including the Bruno Response Elements (BREs) (Kim-
Ha et al., 1995; Reveal et al., 2011). Mutating the BREs reduces Bru binding in 
vitro and leads to precocious expression of Osk in vivo, suggesting that Bru 
binding is essential to prevent premature translation (Kim-Ha et al., 1995). A 
direct evidence for translational repression comes from in vitro assays using cell-
free translation systems from ovary extract, which recapitulates Bru- and BRE-
dependent repression (Lie and Macdonald, 1999; Castagnetti et al., 2000). 
Currently, there are two models for how Bru represses Osk translation. In the first 
model, Bru recruits Cup, an eIF4E-binding protein, blocking initiation of 
translation (Nakamura et al., 2004). In the second model, Bru oligomerizes 
multiple osk mRNAs into large particles that are inaccessible to the translational 
machinery (Chekulaeva et al., 2006).     
The first model comes from data showing that Bru interacts with Cup 
(Nakamura et al., 2004), which in turn interacts with eukaryotic translation 
initiation factor 4E (eIF4E; Wilhelm et al., 2003; Nakamura et al., 2004; 
Zappavigna et al., 2004). Translational initiation requires interaction of several 
initiation factors prior to recruitment of the small ribosomal subunit. eIF4E binds 
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the 5ʼ cap of the mRNA and the scaffold protein eIF4G, which recruits the 43S 
preinitiation complex to the mRNA via interacting with eIF3 (Gebauer and Hentze, 
2004). Cup binds eIF4E on the same surface as eIF4G does, through a 
conserved 4E-binding motif, and competes with eIF4G (Nakamura et al., 2004; 
Zappavigna et al., 2004). Thus the eIF4E-eIF4G interaction is crucial for 
translational initiation and is blocked by Bru-Cup-eIF4E interaction. In cup 
mutants, Osk is prematurely and ectopically translated although the osk mRNA is 
localized to the posterior (Wilhelm et al., 2003; Nakamura et al., 2004).  
The second model is built upon data that Bruʼs RNA binding promotes 
formation of the heavy RNP particles, termed silencing particles, that are 
inaccessible to ribosomes (Chekulaeva et al., 2006). Reporters bearing two 
copies of the AB region were used in a cell-free translation system, and particles 
were fractionated by centrifugation in a sucrose density gradient. The heavy (50-
80S) silencing particles formed in a BRE-dependent manner and were devoid of 
ribosomes. Furthermore, osk oligomerization required the presence of Bru, and 
the silencing particles contained Cup and Me31B proteins, both involved together 
with Bru in translational repression of osk (Chekulaeva et al., 2006). Altogether, 
the data suggest that Bru mediates repression through a mechanism that 
involves packaging of multiple osk transcripts and sequestering them from the 
translational machinery, thus blocking initiation of translation. A concern about 
the significance of these results is that the mRNAs used for in vitro translation 
and fractionation experiments do not resemble the native osk transcript, 
consisting of a short coding region (an epitope tag) and two copies of the osk 3' 
UTR AB region (Chekulaeva et al., 2006). The AB region is comprised almost 
entirely of sequences shown to bind Bru (Kim-Ha et al., 1995; Reveal et al., 
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2011). As a consequence, the mRNA in these experiments consists mostly of 
Bru-binding sites, which may lead to assembly of artificial and non-physiological 
particles. A direct testing of the role of Bru in osk RNP formation has been 
unsuccessful because strong arrest (aret) mutants arrest oogenesis early 
(Schüpbach and Wieschaus, 1991), and the large size of the aret locus (>100 kb) 
creates a significant barrier to making a rescuing transgene.  
Other proteins that associate with the Bru-Cup-eIF4E complex are also 
involved in translational regulation of osk (Wilhelm et al., 2000; Nakamura et al., 
2001). Maternal Expression at 31B (Me31B) is another component of the osk 
RNP and is required for translational repression of osk (Nakamura et al., 2001). 
In me31B-mutant egg chambers, Osk expression is seen ectopically in nurse 
cells during early stages. Me31B is a DEAD-box RNA helicase (De Valoir et al., 
1991), and the yeast homolog of Me31B, Dhh1p, is an mRNA-decapping 
activator in P bodies (Coller and Parker, 2005). P bodies are large RNPs devoid 
of ribosomes and are found in eukaryotes from budding yeasts to humans 
(Eulalio et al., 2007). Although P bodies were originally identified as sites of 
mRNA decay (Sheth and Parker, 2003), additional studies revealed a broader 
role in many aspects of RNA regulation, such as mRNA storage and translational 
repression (Brengues et al., 2005; Bhattacharyya et al., 2006). The components 
of the P bodies are highly conserved across species and are shared with the 
sponge bodies of Drosophila (Kato and Nakamura, 2012). GFP-Me31B forms 
cytoplasmic particles in the nurse cells and oocyte and colocalizes with the osk 
mRNA in sponge bodies (Nakamura et al., 2001). Sponge bodies are 
amorphous, electron-dense structures that contain tubular ER-like membrane-
cisternae (Wilsch-Brauninger et al., 1997) and a large number of post-
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transcriptional regulatory factors and localizing mRNAs including osk (Snee and 
Macdonald, 2009). Sponge bodies change their composition rapidly upon entry 
into the oocyte from the nurse cells (Snee and Macdonald, 2009), suggesting that 
the osk RNP could be a dynamic particle undergoing remodeling of trans-acting 
factors in different regions within the egg chamber.   
 
TRANSLATIONAL ACTIVATION OF OSKAR UPON POSTERIOR 
LOCALIZATION 
It still remains unknown how translation of Osk protein is activated once 
the osk transcript reaches the posterior pole of the oocyte. There must be 
derepression by removal or inactivation of Bru and other repressors. In addition, 
there may also be activation by recruitment of an activator. Whatever the 
mechanism, spatial cues likely mediate localized translation since activation is 
coordinated with localization.  
Interestingly, Bru-binding sites are not only required for repression, but 
also required for activation of translation (Reveal et al., 2010). When only the C-
region BREs are mutated, activation of translation is defective. As noted earlier, 
mutation of both AB- and C-region BREs disrupts repression, and so the C-
region BREs have roles in both repression and activation. The fact that mutation 
of all BREs leads to a loss of repression and excess Osk indicates that the C-
region-mediated activation is not required when repression is defective. Since the 
BREs are bona fide Bru binding sites, and mutating Bru binding sites other than 
the BREs in the C region also leads to similar defects, Bru is the most likely 
candidate for an activator (Reveal et al., 2010). Since the contribution of the C-
region BREs in activation is most pronounced in late-stage oocytes and early 
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embryos, Bru may switch its function from a repressor to an activator during late 
oogenesis. How this occurs is not known, but could involve a post-translational 
modification.  
There are additional cis elements important for translational activation of 
osk: Imp-binding elements (IBEs) and a 5ʼ activating element (Fig 1.3). IBEs are 
motifs found in multiple copies within the osk 3ʼ UTR and binding sites for the 
Drosophila homolog of insulin growth factor II mRNA-binding protein (IMP). 
Mutating subsets of IBEs results in defects in Osk accumulation and posterior 
patterning (Munro et al., 2006), although Imp mutants have no defects in osk 
regulation (Geng and Macdonald, 2006; Munro et al., 2006). The 5ʼ activating 
element is a poorly characterized region within the coding sequence between the 
start codons for Long and Short Osk. Inversion of the 3ʼ half within this 130nt 
region abrogates binding of two ovarian proteins: p50, later identified as Hrp48; 
and p68, whose identity remains unknown (Gunkel et al., 1998; Yano et al., 
2004). The effect of the inversion on expression was monitored using a lacZ 
reporter mRNA, which contains the osk 5ʼ region up to the downstream AUG for 
the Short Osk, fused to the lacZ coding sequence, followed by the entire osk 3ʼ 
UTR. In this reporter, the inversion mutation prevents posterior accumulation of 
the β-galactosidase activity (Gunkel et al., 1998). Although the 5' element and 
IBEs function in activation of translation, the trans-acting proteins that bind them 
to mediate activation are unknown.  
One way in which Bru could mediate activation is through recruitment of 
Vasa (Vas) to the osk mRNA. Vas is an ATP-dependent, DEAD-box RNA 
helicase, and is recruited to the posterior pole to function in posterior patterning 
and germ cell formation, similar to Osk (Schüpbach and Wieschaus, 1986; Hay et 
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al., 1988; Lasko and Ashburner, 1990). Bru interacts with Vas directly (Webster 
et al., 1997) and may recruit Vas to osk. Consistent with this idea, Vas 
colocalizes with the osk transcript to the posterior pole of the oocyte from stage 9 
of oogenesis (Liang et al., 1994), and is required for efficient Osk translation 
(Markussen et al., 1995; Rongo et al., 1995). The defect in Osk accumulation 
only appears late in oogenesis (Harris and Macdonald, 2001). It has been shown 
that the RNA-binding and helicase activities of Vas are dispensable for its 
posterior localization (Liang et al., 1994), and thus protein-protein interaction may 
account for localization of Vas. Another possibility is that Vas binds osk directly to 
activate translation. Vas binds directly and specifically to a U-rich motif within the 
mei-P26 3ʼ UTR to activate its translation (Liu et al., 2009). Similarly, Vas could 
be recruited to osk by a U-rich motif present in the osk 3ʼ UTR. vaso11 and vaso14 
mutants, which are defective in RNA binding in vitro, are unable to support pole 
cell formation, although these Vas mutants localize to the posterior pole like the 
wild type (Liang et al., 1994). Therefore interaction of Vas with osk mRNA and 
subsequent RNA-unwinding activity may be the key to efficient Osk translation 
and pole cell formation.  
Another way in which Bru could mediate activation is through recruitment 
of Orb to the osk mRNA. Orb is a Drosophila homolog of Xenopus CPEB, a 
protein that binds the U-rich cytoplasmic polyadenylation element (CPE; Hake 
and Richter, 1994; Stebbins-Boaz et al., 1996) and presumably recruits and 
stabilizes the cytoplasmic polyadenylation machinery (Mendez et al., 2000). In 
many species, mRNAs with a long poly(A) tail are translationally active while 
those with a short poly(A) tail are translationally inactive. In Drosophila, no 
canonical CPE has been identified, but a protein that comigrates with Orb can be 
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UV-crosslinked to the osk 3ʼ UTR (Chang et al., 1999). Alternatively, Orb could 
be recruited to osk via interaction with Bru, with which Orb interacts physically 
and genetically (Castagnetti and Ephrussi, 2003). Orb colocalizes with the osk 
mRNA, and the osk mRNA is mislocalized in strong orb mutants (Christerson and 
McKearin, 1994; Lantz et al., 1994). In weak orb mutants, the poly(A) tail of osk 
is shorter in length, and posterior Osk is greatly reduced at stages 9 and 10 
(Chang et al., 1999; Castagnetti and Ephrussi, 2003), even in egg chambers that 
display correct Stau localization (Castagnetti and Ephrussi, 2003). Therefore, Orb 
could stimulate Osk translation by elongating or maintaining (via protection from 
degradation) the poly(A) tail.  
Like Orb, Staufen (Stau) is involved in both osk mRNA localization and 
translational activation, two processes that are coupled and hard to tease apart 
when assessing the mutant phenotype. However, two processes are uncoupled 
in mothers expressing the oskBRE- transgene, which has mutations in both AB 
and C regions and thus causes defects in repression and produces bicaudal 
embryos (Kim-Ha et al., 1995). Embryos from orb- or stau-mutant mothers have 
abdominal deletions (Schüpbach and Wieschaus, 1986; Christerson and 
McKearin, 1994), due to defects in osk mRNA localization (Ephrussi et al., 1991; 
Kim-Ha et al., 1991; Christerson and McKearin, 1994; Lantz et al., 1994). 
Although the orb-mutant phenotype is rescued by the oskBRE- transgene, the 
stau-mutant phenotype is not (Kim-Ha et al., 1995); this result suggests that stau 
has a role in activation of translation, which is required in the absence of 
repression, independent of its role in osk localization. Consistent with this, the 
dsRNA-binding domain 5 (dsRBD5) of Stau does not bind dsRNA in vitro, unlike 
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four other dsRBDs that do, yet dsRBD5 is required for translation of localized osk 
mRNA at the posterior (Micklem et al., 2000).  
There are examples of kinases that locally phosphorylate RNA-binding 
proteins to release them from targets and lead to translational activation (Besse 
and Ephrussi, 2008). One candidate kinase that could provide the spatial and 
temporal cue for Osk translation is cAMP-dependent Protein Kinase (PKA). PKA 
is the key mediator of the ubiquitous second messenger, cAMP, in various 
signaling events. The PKA holoenzyme consists of two regulatory subunits (R) 
and two catalytic subunits (C). Upon cAMP binding, the regulatory subunits 
release the catalytic subunits, which are freed to phosphorylate their substrates 
(Taylor et al., 1990). Regulation of PKA activity has been shown to be crucial for 
spatial restriction of Osk. Pka-R1 mutants, which display increased PKA catalytic 
activity, produce bicaudal embryos and cause premature and ectopic expression 
of Osk; this patterning defect is suppressed by reducing the catalytic gene 
dosage (Yoshida et al., 2004). PKA-R1 is expressed in the cytoplasm of the 
nurse cells, follicle cells, and the oocyte and enriched at membranes (Yoshida et 
al., 2004). PKA also regulates microtubule polarity in the oocyte. DC0 encodes 
the PKA catalytic subunit in Drosophila (Lane and Kalderon, 1993). DC0 mutants 
alter oocyte microtubule distribution, such that a high density of microtubules are 
ectopically seen at the posterior of stage 7 and 8 oocytes, concomitant with 
aberrant localization of Kin:β-gal, the plus-end marker, to the center of the oocyte 
(Lane and Kalderon, 1994). Signaling between the oocyte and somatic follicle 
cells is essential for correct anteroposterior axis specification via reorganization 
of microtubules during mid oogenesis (González-Reyes et al., 1995; Roth et al., 
1995). Correct localization of Kin:β-gal at the posterior of the oocyte depends on 
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PKA activity in the germline, rather than soma, and this finding led to the 
postulation that PKA activity is required in the germline for transducing a 
temporal signal from the posterior pole at stage 6/7 for reorganization of the 
microtubules (Lane and Kalderon, 1994). This germline requirement of PKA at 
the time of oocyte polarity formation coincides with subsequent osk localization 
and translation. Therefore, PKA is an ideal candidate to locally inactivate Bru, 
directly or indirectly, and lead to derepression of osk translation.  
 
SUMMARY AND CONCLUSION 
Embryonic axis formation is mediated through subcellular localization and 
translational control of maternal determinants. Correct spatial and temporal 
control of Osk expression is essential for axial patterning of the embryo, and is 
achieved by coupling of mRNA localization and translational regulation. The osk 
RNP particles are thought to form in the nurse cells and move to their final 
destination within the oocyte. Many trans-acting factors associated with the osk 
RNP are essential for localization and/or translational regulation, allowing 
coupling of the two processes. Once the osk mRNA is localized to the posterior 
of the oocyte, translational repression must be relieved to allow for Osk 
accumulation. This could occur by inactivation or displacement of repressors, 
most likely via post-translational modifications. In addition to derepression, 
translation of Osk may also require activation, which could involve enhancement 
of translation by elongating the poly(A) tail, for example. Local signaling is likely 
involved to activate translation of osk. Although many translational regulatory 
factors have been identified, it still remains mysterious how these factors 
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coordinate their actions to execute a spatially and temporally precise outcome. 
Therefore elucidating the mechanism of translational control of osk would 
contribute to unraveling a layer of post-transcriptional control exerted on 
developmentally critical RNAs.   
 
OVERVIEW OF THE DISSERTATION RESEARCH 
The main goal of my dissertation research is to elucidate the regulatory 
mechanisms of osk translation. I used two approaches: mutating Bru to disrupt 
interactions with negative regulators of osk and altering the activity of a positive 
regulator of osk.  
Bru interacts with Cup and with itself, and the current models of repression 
likely depend on Bru dimerization and Cup binding. I found that the amino-
terminal domain of Bru contributes to both interactions, and deletion of this 
domain causes a defect in translational repression. However point mutations, 
within the amino-terminal domain, that disrupt both types of interaction in vitro did 
not interfere with translational repression in vivo. Moreover, the same mutations 
made in the context of the endogenous arrest gene, which encodes Bru, did not 
cause any patterning defects associated with misregulation of osk. Therefore, 
according to the results of my in vitro binding assays, Bru-Cup and Bru-Bru 
interactions could act redundantly with another form of repression that also acts 
through the amino-terminal domain. Alternatively, the defects in binding in vitro 
may exaggerate the defects in vivo, and residual interactions could suffice for 
efficient repression. Interestingly, dimerization-defective Bru only weakly 
accumulated Osk::GFP fusion protein encoded by an osk::GFP reporter RNA 
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bearing a Bru-binding region, while dimerization-competent Bru showed the 
opposite effect. These unexpected results suggest a new role of dimerization in 
translational activation.   
A small fraction of Bru in ovaries is phosphorylated. PKA is a positive 
regulator of osk expression and phosphorylates Bru in vitro. To test if PKA 
regulation of osk is mediated through Bru, I examined the effect of altering PKA 
activity on Bru phosphorylation and Bru-mediated repression. Modulating PKA 
activity had small, yet detectable changes in Bru phosphorylation and Bru-
dependent translational repression using an osk::GFP reporter. While the studies 
with Bru mutants suggest that phosphorylation promotes repression by Bru, 
however, the positive effect of PKA on osk expression may occur by 
phosphorylating additional targets. It also remains possible that there are 
additional sites of phosphorylation that inactivates Bruʼs repressive activity.  
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FIGURES 
 
Figure 1.1. Localization of maternal RNAs that specify axial patterning in a 
Drosophila oocyte 
An egg chamber contains germline-derived nurse cells and oocyte, and 
somatic follicle cells that surround the oocyte (and nurse cells at earlier stages). 
Three localized determinants are shown in a stage 10 egg chamber. 
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Figure 1.2. Egg chamber progression through oogenesis from germarium 
to stage 14 
Egg chambers develop as they move toward the posterior of an ovariole 
within Drosophila ovaries. The germarium holds germline and somatic stem cells 
that give rise to cells in an egg chamber, which buds off from the tip of the 
germarium. Nurse cells degenerate near the end of oogenesis. 
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Figure 1.3. A schematic diagram of oskar mRNA and Oskar protein 
Two large boxes represent the coding sequence, and two horizontal lines 
are the 5ʼ or 3ʼ UTRs. The wavy lines represent two Osk isoforms made from 
alternative start codons in the same reading frame. Cis elements involved in 
repression are depicted in red, and cis elements involved in activation are in 
green. Bru-binding sites are embedded in two regions within the 3ʼ UTR: AB (red 
box) and C (red/green box). 
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Chapter 2: Role of Bruno Protein Interactions in Translational 
Regulation of oskar1 
 
ABSTRACT 
Oskar (Osk) is a posterior body-patterning determinant in Drosophila and 
is highly concentrated at the posterior pole of the oocyte. Tight spatial and 
temporal restriction of the Osk patterning activity is essential for proper 
development of the embryo. Bruno (Bru) directly binds to the osk mRNA and 
represses translation during mRNA localization to the posterior pole. After osk 
mRNA localization, repression must be alleviated to allow accumulation of Osk 
protein. In one model for repression, Bru bound to osk mRNA recruits Cup, which 
in turn binds eIF4E and prevents its interaction with eIF4G. In another model, Bru 
promotes oligomerization of multiple osk mRNAs into large particles that are 
inaccessible to the translational machinery. The interactions of Bru with RNA and 
proteins must underlie its repressive activity, and may be disrupted for release 
from repression. We show that Bru dimerizes, with the amino-terminal domain 
contributing to both dimerization and interaction with Cup. Deletion of this domain 
disrupts translational repression by Bru in an in vivo assay. We also show that a 
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small fraction of ovarian Bru is phosphorylated. Several predicted sites of 
phosphorylation by PKA in Bru lie within the amino-terminal domain, with at least 
one of these being phosphorylated by PKA in vitro. Phosphomimetic mutations in 
these sites interfere with Bru binding to both Cup and itself in vitro, while the 
corresponding phosphosilent mutations have no effect. However the 
phosphomimetic mutations do not interfere with translational repression in vivo. 
Surprisingly, Bru dimerization appears to be important for translational activation, 
not repression, an implication at odds with one model of repression. 
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INTRODUCTION 
Post-transcriptional gene regulation fine-tunes the amount and location of 
many gene products that are essential for development. In Drosophila, 
localization of several determinants within a single large cell, the oocyte, is 
required for correct axis formation and body patterning (reviewed in Lipshitz and 
Smibert, 2000; Palacios and St. Johnston, 2001).  
Oskar (Osk) is a posterior determinant that specifies formation of the 
embryonic abdomen and germline (reviewed in St Johnston and Nüsslein 
Volhard, 1992). In the absence of Osk, no abdomen and germ cells form 
(Lehmann and Nüsslein Volhard, 1986). Conversely, overexpression of Osk can 
cause a range of defects, from anterior patterning defects at a low level to a 
mirror-image duplication of abdominal segments (the bicaudal phenotype) at a 
high level (Smith et al., 1992). Similarly, specific misexpression of Osk at the 
anterior efficiently produces bicaudal embryos (Ephrussi and Lehmann, 1992). 
Thus, proper deployment of Osk is critical for embryonic pattern formation, 
viability and fertility.  
The osk mRNA is transcribed in nurse cells and transported into the 
oocyte early in oogenesis. Then the mRNA is localized to the posterior pole at 
stage 9 of oogenesis and remains anchored there until early embryogenesis 
(Kim-Ha et al., 1991; Ephrussi et al., 1991; Rongo et al., 1995, Vanzo and 
Ephrussi, 2002). Translation of osk is repressed until the mRNA is localized, and 
this coupling of RNA localization and translation is essential for restricting the 
Osk activity to the posterior pole (Kim-Ha et al., 1995; Rongo et al., 1995; 
Markussen et al., 1995).  
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Bruno (Bru; encoded by the gene arrest or aret) is an RNA-binding protein 
containing three RNA Recognition Motifs (RRMs) commonly found in many RNA-
binding proteins. The two tandem RRMs are positioned near the amino terminus, 
separated from a third RRM at the carboxyl terminus by a linker region (Webster 
et al., 1997; Snee et al., 2008). Bru directly binds the osk 3ʼ UTR in two regions: 
AB close to the coding sequence and C close to the poly(A) tail. Each region 
contains multiple Bru-binding sites, including the Bruno Response Elements 
(BREs) (Kim-Ha et al., 1995; Reveal et al., 2011). Mutation of the BREs disrupts 
Bru binding to osk mRNA, resulting in excess Osk activity and bicaudal 
phenotype, and implicating Bru as a translational repressor (Kim-Ha et al., 1995; 
Reveal et al., 2010). Direct evidence for translational repression comes from in 
vitro assays using cell-free translation systems from ovary extracts, which 
recapitulate Bru- and BRE-dependent repression (Lie and Macdonald, 1999; 
Castagnetti et al., 2000).  
Currently, there are two models for repression of osk translation. In the 
first, Bru recruits Cup, and Cup binds eIF4E through the conserved eIF4E-
binding motif shared by many eIF4E-binding proteins, including eIF4G 
(Nakamura et al., 2004; Zappavigna et al., 2004). Consequently, the Cup-eIF4E 
interaction competitively blocks the eIF4E-eIF4G interaction, which is necessary 
for translational initiation. Cup interacts with both Bru and eIF4E in the absence 
of RNA, and several cup mutants express Osk precociously and ectopically 
(Wilhelm et al., 2003; Nakamura et al., 2004). In the second model, Bru promotes 
osk mRNA oligomerization and formation of large silencing particles, which are 
inaccessible to the ribosomes. Using a reporter mRNA consisting of a FLAG 
epitope tag and two copies of the osk 3' UTR AB region, Chekulaeva et al 
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showed that translational repression was accompanied by the formation of 
unusually heavy RNPs containing Bru. In separate assays, they also showed that 
Bru and BREs are required to form the osk oligomers (Chekulaeva et al., 2006). 
In summary, the ability of Bru to bind Cup is essential for one model of 
repression, and the ability of Bru to oligomerize osk RNA is essential for the other 
model, but these functions have not been directly tested for an effect on 
translational repression.  
Regulation of cAMP-dependent Protein Kinase (PKA) activity is critical for 
regulation of osk mRNA. Upregulating the activity of PKA causes a bicaudal 
phenotype, due to precocious and ectopic expression of Osk. Downregulating 
PKA activity results in reduced Osk expression despite correct mRNA localization 
(Yoshida et al., 2004). Posterior localization of osk mRNA requires microtubules. 
Early in oogenesis, the microtubules are nucleated from a microtubule-organizing 
center (MTOC) at the oocyteʼs presumptive posterior (Theurkauf et al., 1993). 
During stage 6/7, the microtubule network undergoes a drastic rearrangement - 
the MTOC at the posterior disassembles, and microtubules are nucleated from 
anterior and lateral cortices, with plus ends enriched at the posterior of the oocyte 
(Theurkauf et al., 1992; Lane and Kalderon, 1994). Reorganization of 
microtubules requires two sequential signaling events between the oocyte and 
somatic follicle cells: from the oocyte to the follicle cells, and then from the follicle 
cells back to the oocyte (González-Reyes et al., 1995; Roth et al., 1995). PKA 
activity is required in the germline to establish the correct polarity of microtubules, 
which is essential for proper RNA localization including osk (Lane and Kalderon, 
1994). Thus, it has been suggested that PKA activity in the oocyte transduces a 
temporal signal from the posterior follicle cells to reorganize the microtubule 
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network during mid oogenesis (Lane and Kalderon, 1994; González-Reyes et al., 
1995; Roth et al., 1995). This germline requirement of PKA at the time of oocyte 
polarity formation coincides with subsequent osk localization and translation. 
Although PKA activity positively regulates Osk expression, it is not known if PKA 
acts directly on regulators of osk translation, by inactivating a repressor or 
activating an activator via phosphorylation.   
Here we demonstrate that Bru dimerizes, and characterize the binding of 
Bru to itself and to Cup. We show that Bru is phosphorylated in vivo, and that 
PKA phosphorylates Bru in vitro. Phosphomimetic mutations eliminate Bru 
dimerization and reduce the Bru-Cup interaction. Notably, these mutations do not 
disrupt translational repression in vivo. Surprisingly, Bru dimerization appears to 
be important for translational activation, not repression, an implication at odds 
with the silencing particles model of repression. 
 
RESULTS 
Bruno dimerizes via a domain that also mediates Cup binding 
A GST pull-down assay was used to test for the ability of Bru to dimerize. 
Full-length Bru was expressed as a fusion to GST, and incubated with Bru 
bearing a His6 tag. Following affinity purification of GST::Bru with glutathione 
agarose beads, copurification of His6::Bru was tested by Western blot analysis 
using the anti-His6 antibody. By this assay, Bru did dimerize, while His6::Bru did 
not bind to GST alone (Fig 2.1A).  
To map the domain of Bru responsible for dimerization, deletion 
derivatives of Bru (Fig 2.2B) were tested in the GST::Bru pull-down assay. The 
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three RRMs all function in RNA binding (Snee et al., 2008), so we focused on the 
other domains. Deletion of the Bru amino-terminal domain (aa1-146) eliminated 
binding to GST::Bru, while deletion of most of the linker domain between RRMs 2 
and 3 (aa334-416) had no effect. The amino terminal domain is not only required 
for dimerization with Bru, but is also sufficient: the isolated domain bound 
GST::Bru (Fig 2.2A and 2.2B). The ability of Bru to dimerize provides a simple 
explanation for how Bru oligomerizes osk mRNA: a molecule of Bru bound to one 
osk mRNA could dimerize with a second molecule of Bru bound to a different osk 
mRNA. With the many Bru-binding sites in the osk mRNA 3' UTR, formation of 
large, highly interconnected protein-RNA assemblies is possible. This suggests 
that the proposed use of osk mRNA oligomerization as a mechanism of 
translational repression likely relies on Bru dimerization.  
A second Bru interaction, with Cup, provides the basis for the other 
proposed mechanism of translational repression, in which Bru recruits Cup to the 
osk mRNA (Nakamura et al., 2004). We used a GST::Cup pull-down assay to 
monitor interaction with Bru. As expected, full-length Bru (Bru+) bound GST::Cup. 
Deletion of either aa1-146 or aa334-416 had no dramatic effect on binding, but 
deletion of both domains eliminated binding. Just as for Bru dimerization, the 
isolated amino-terminal domain was sufficient for binding to GST::Cup (Fig 2.2A 
and 2.2B).  
The results showing that deletion of the Bru amino-terminal domain did not 
disrupt the interaction between Bru and Cup proteins were obtained using 
purified recombinant proteins. We also performed similar assays using unpurified 
Bru proteins, expressed in the same manner but still in the bacterial extracts 
where other proteins can compete for binding interactions. In this modified assay, 
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deletion of the amino-terminal domain did reduce binding to Cup, while deletion 
of aa334-416 had no dramatic effect. This suggests that the Bru amino-terminal 
domain is more important for Cup binding than is the linker domain (Fig 2.1B).  
 
Deletion of the amino-terminal domain interferes with Bruno-dependent 
translational repression 
Our evidence that the amino-terminal domain of Bru is essential for 
dimerization and contributes to Cup binding suggests that this domain is likely to 
play an important role in repression. To test this prediction we established an in 
vivo tethering assay, in which we monitor translation of a GFP-MS2 reporter 
mRNA. The 3' UTR of the GFP-MS2 mRNA includes 18 copies of the 
bacteriophage MS2 stem loop, which is a binding site for the MS2 coat protein 
(MCP; Bardwell and Wickens, 1990). Forms of Bru are expressed as fusions to 
MCP, so that they become bound to the reporter mRNA. Both the reporter mRNA 
and tethered Bru proteins are expressed in Drosophila ovaries using the 
UAS/GAL4 system. Levels of the MCP::Bru fusion proteins were determined by 
Western blot; all transgenic lines used here were expressed at similar levels (Fig 
2.3A).  
The GFP-MS2 reporter by itself was expressed throughout the germline 
cells of the egg chamber (Fig 2.4A). Coexpression of tethered Bru dramatically 
reduced GFP level (10 fold; Fig 2.4C), with a more modest reduction in the GFP-
MS2 mRNA level (1.7 fold; Fig 2.3C). Therefore, in this assay Bru is both 
repressing translation and reducing mRNA stability, although repression is the 
stronger effect (compare Fig 2.4J and Fig 2.4L). By contrast, a control MCP 
fusion protein did not cause a reduction in GFP (Fig 2.4B).  
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Testing mutants of Bru in this assay revealed that deletion of the amino-
terminal domain of Bru led to a substantial increase in GFP (Fig 2.4F). Deletion 
of the linker domain by itself had no strong effect on GFP level (Fig 2.4G), but did 
enhance the effect of deleting the amino-terminal domain (Fig 2.4H). To 
determine to what extent the changes in GFP level were due to effects on 
translational repression and mRNA stability, reporter mRNA levels were 
measured. Both mutants with enhanced GFP also had elevated GFP-MS2 mRNA 
(Fig 2.4L), although the changes were strongest at the protein level (Fig 2.4J and 
2.4K). Thus, the deletions interfere with both activities of Bru in this assay: 
translational repression and destabilization of mRNA.   
We also tested the amino-terminal domain by itself in the tethering assay. 
This domain supported an intermediate level of repression (Fig 2.4I). 
The results of the tethering assay are consistent with either of the current 
models of translational repression by Bru, since disrupting dimerization and 
interaction with Cup are predicted to disrupt repression. Our observation of an 
effect of Bru on mRNA stability also fits with evidence showing that Cup-
dependent repression involves a change in mRNA stability in Drosophila S2 cells 
(Igreja and Izaurralde, 2011). An effector domain of Cup was shown to 
destabilize reporter mRNAs to which it was tethered via deadenylation-
dependent decapping and degradation, in addition to translational repression 
independent of deadenylation (Igreja and Izaurralde, 2011).  
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Bruno is a phosphoprotein 
To allow translation of the osk mRNA once it has been localized to the 
posterior pole of the oocyte, there must be a release from repression. How this is 
accomplished is not known, but one possibility is that Bru is post-translationally 
modified to inhibit its repressive activity. To ask if Bru is phosphorylated, the 
conventional approach of testing for phosphatase-dependent changes in 
electrophoretic mobility of the protein was used. In untreated ovary extract, Bru 
appeared by Western blot analysis as a major band, with a faint lower-mobility 
band. Treatment with phosphatase eliminated the weak band. By contrast, 
addition of phosphatase inhibitors enhanced the minor band, consistent with the 
interpretation that this small fraction of Bru is phosphorylated (Fig 2.5A left).  
To make a more compelling case for phosphorylation, we also tested the 
MCP::HA3::Bru 1-146 protein from above, which at 32 kDa is substantially 
smaller than Bru (64 kDa) and thus might display a larger change in mobility from 
phosphorylation. This was indeed the case, and the difference between the major 
Bru band and the slower migrating fraction was more dramatic (Fig 2.5A right). 
Bru phosphorylation was also analyzed using the phosphate-affinity SDS-PAGE 
with the acrylamide-pendant Phos-tag, which separates different phosphoprotein 
isoforms. Using this approach, multiple, different phosphorylated species could 
be detected (Fig 2.6A).  
 
Bruno is phosphorylated by PKA 
To identify candidate phosphorylation sites in Bru, we used the NetPhosK 
1.0 and KinasePhos prediction programs. Both report multiple sites for many 
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different kinases, although none of the candidate sites had scores suggesting a 
high probability of phosphorylation (data not shown). Nevertheless, Bru is 
phosphorylated and so even sites with modest scores remain as candidates. 
Several amino acids are predicted to be targets for the Protein Kinase A (PKA), 
an interesting option since alteration of PKA activity affects osk expression 
pattern and embryonic body patterning (Yoshida et al., 2004).  
To evaluate PKA, in vitro phosphorylation assays were performed using 
the PKA catalytic subunit and full-length Bru. Bru was strongly phosphorylated, 
while BSA (a negative control) was not (Fig 2.7A). By contrast, neither Casein 
Kinase I (CK1) nor Calmodulin-dependent Protein Kinase II (CaMKII), which 
have similar recognition motifs to that of PKA, supported detectable 
phosphorylation of full-length Bru (Fig 2.7B).  
To map the sites of phosphorylation, the Bru deletion proteins used to map 
interaction domains were used as substrates (Fig 2.2B). The results demonstrate 
that PKA phosphorylates one or more sites in the amino-terminal region of Bru: 
deletion of this domain greatly reduced phosphorylation, and the isolated domain 
was itself phosphorylated. The linker region is not required for phosphorylation, 
as deletion of this region did not reduce the level of phosphorylation. Deletion of 
both the amino-terminal and linker domains reduced phosphorylation to the same 
low level as seen with deletion of just the amino-terminal domain (Fig 2.5B).  
To identify where PKA phosphorylates Bru in its amino-terminal domain, 
we performed a tandem mass spectrometry (MS/MS) analysis of Bru 
phosphorylated in vitro. Although four candidate sites are predicted, only 
phosphoserine at position 7 (S7) was identified with high confidence and no 
ambiguity (Fig 2.5D). A majority of peptides containing either S4 or T135 was 
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detected as unphosphorylated; S88 could not be tested since aa36-119 was 
undetectable due to a low coverage of MS/MS (see Materials and Methods). 
Nevertheless, there is still a possibility of weak phosphorylation below the limit of 
detection at either S4 or T135, and we cannot rule out phosphorylation within the 
aa36-119 region. Consistent with S7 phosphorylation, mutation of S7 to alanine 
(S7A) substantially reduced phosphorylation by PKA in vitro. Because the S7A 
mutant retained a low level of phosphorylation, we also tested additional 
mutations in other predicted sites, either alone or in combinations. Of the mutants 
tested, the protein with all three mutations, S4A/S7A/T135A, was most resistant 
to phosphorylation (Fig 2.5C). All mutations except for S4A were also made in 
the context of the full-length Bru to test their effect on phosphorylation, and 
similar results were obtained (Fig 2.6B).  
 
Phosphomimetic mutations disrupt Bruno dimerization and Cup binding 
Since the amino-terminal domain of Bru is important for both dimerization 
and interaction with Cup - interactions that underlie the models for how Bru 
represses translation -, the potential phosphorylation of one or more residues 
within this region might inhibit repression. As a first step in testing this possibility 
we asked if phosphomimetic mutations would interfere with Bru protein 
interactions.  
Pull-down assays were performed with GST::Cup and GST::Bru, using Bru 
mutants with phosphosilent alanine (A) or phosphomimetic glutamate (E) 
substitutions at one or more of the three residues that affect phosphorylation by 
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PKA: S4, S7, and T135. The full-length protein with no mutations (Bru+) served 
as a positive control, and Δ1-146 Δ334-416 as a negative control.  
None of the phosphosilent mutants showed reduced binding to GST::Bru 
(Fig 2.8A) or GST::Cup (Fig 2.8B), demonstrating that mutation of the affected 
residues does not inherently disrupt the protein interactions. By contrast, the 
phosphomimetic mutants did display reduced or undetectable binding, with 
dimerization being more sensitive to the changes. The S7E mutation significantly 
reduced dimerization, and the S4E/S7E double mutant retained only a very low 
level of dimerization. Including the T135E mutation did not obviously further 
reduce dimerization by S7E (in S7E/T135E), but did reduce dimerization of the 
triple mutant (S4E/S7E/T135E) to below the level of detection (Fig 2.8A and 
2.8C).  
Bru binding to Cup was less sensitive to the phosphomimetic mutations. 
The S7E single mutation did not affect binding, and the double mutation 
combinations caused only modest defects. Binding to Cup was, however, 
strongly reduced for the S4E/S7E/T135E triple mutant (Fig 2.8B and 2.8C).  
Since S4E/S7E/T135E triple mutant has the most severe defect in both 
types of Bru interaction, we might expect to see a corresponding defect in 
translational repression given the existing models.  
 
Phosphomimetic mutations in the candidate phosphorylation sites impair 
Brunoʼs RNA-binding activity 
Cooperative binding is a common strategy to enhance affinity for a 
substrate. Dimerization of Bru might facilitate cooperative binding to RNA, and if 
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so, the mutations inhibiting dimerization are expected to impair Bruʼs RNA-
binding activity.  
A UV-crosslinking assay was used to test Bru proteins for their ability to 
bind the osk 3' UTR AB region RNA, which has multiple Bru-binding sites. The 
two mutants most strongly defective in dimerization, S4E/S7E and 
S4E/S7E/T135E, showed compromised RNA binding (Fig 2.9A). After 
quantitation, normalization for protein levels and statistical analysis of three 
independent experiments, both mutants were considered to have a significant 
change in their RNA-binding ability when compared to their ala-mutant 
(dimerization-competent) counterparts (Fig 2.9B).  
In addition to disrupting known protein interactions underlying the current 
models of repression, phosphomimetic glu mutations may interfere with 
translational repression by simply reducing the affinity for the substrate mRNAs.  
 
Mutations that inhibit Bruno dimerization and Cup binding do not affect 
repression 
Our analysis of PKA phosphorylation of Bru in vitro suggests that PKA 
may also modify the protein in vivo. Testing this prediction has proven to be 
challenging, and we have not been able to obtain a conclusive answer because 
we were not able to make an antibody against the phospho-S7 peptide. 
Nevertheless, the Bru mutants with defects in dimerization and Cup binding 
provide useful tools to test the importance of these interactions for Bru function. 
As one such test, we made use of the tethering assay to monitor translational 
repression. Surprisingly, none of the mutants showed any notable decrease in 
repression: repression by wild-type Bru reduced the GFP signal from the reporter 
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mRNA close to the background level, and the results for each of the mutants 
were similar (Fig 2.10). All Bru proteins were expressed at similar levels (Fig 
2.3B), and the GFP-MS2 RNA level was similar in all cases (Fig 2.3C).  
MCP is known to dimerize (LeCuyer et al., 1995). This property could 
substitute for Bru dimerization, and thus neutralize the effect of the dimerization-
defective mutations. To rule out a dimerization artifact associated with the MCP-
MS2 system, we used another tethering system which relies on binding of a 
bacteriophage lambda N peptide to the boxB stem-loop RNA (De Gregorio et al., 
1999). In this case the reporter mRNA is GFP with 6 copies of the boxB 
sequence in the 3' UTR (GFP-boxB), and the Bru proteins are expressed as 
fusions to λN peptide. Just as with the other system, tethered Bru repressed 
translation of the reporter mRNA (compare Fig 2.11A and B). Notably, the triple 
glu mutant did not affect repression (Fig 2.11C), confirming that dimerization is 
not required for translational repression.  
 
Dimerization-defective Bruno mutants show normal Oskar expression 
pattern and body patterning activity  
Although two different tethering assays each show that mutations 
disrupting Bru dimerization have no effect on translational repression, the ideal in 
vivo test would be to assay these mutations in the context of intact Bru. To do so 
we used homologous recombination (HR) to exchange exons that encode the 
amino-terminal region of Bru. The replacement regions were wild type (aret+), 
S4A/S7A/T135A (aretala), or S4E/S7E/T135E (aretglu). Loss of aret function 
leads to an early arrest of oogenesis, with no oocyte specified. Females, in which 
the HR replacement alleles provided the only copy of aret, all displayed normal 
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progression through oogenesis. Embryos obtained from these females were 
tested for patterning defects. Although misregulation of osk expression - either 
too little or too much Osk activity - causes striking patterning defects, no such 
defects were found for any of the aret HR alleles. The only phenotype detected 
was for the aretglu mutant, and was unrelated to any known osk defect: an 
increase in the proportion of embryos that fail to develop (Table 2.1).  
To directly test if ala and glu mutations have an effect on Osk expression, 
Osk was monitored during oogenesis. We used two osk transgenes for this 
analysis, both based on a rescuing genomic DNA osk transgene. The osk::HA 
transgene is tagged with an epitope for sensitive immunodetection. The osk::GFP 
transgene allows detection of Osk during late stages of oogenesis, when 
deposition of the vitelline membrane prevents access by antibodies and thus 
precludes the use of whole-mount immunofluorescent detection. These 
transgenes were introduced into the aret+, aretala or aretglu backgrounds.  
Like endogenous Osk, Osk::HA (Fig 2.12D) and Osk::GFP (Fig 2.12G) 
appear in a tight posterior crescent from stage 9 onward. There was no defect in 
repression in stage 8 (Fig 2.12A-C) egg chambers, and we did not detect any 
difference in Osk expression pattern among the three replacement lines in stage 
9 (Fig 2.12D-F) or later (Fig 2.12G-I) egg chambers, consistent with the absence 
of any patterning defects (Table 2.1).   
 
Bruno mutants competent or defective in dimerization have opposing 
effects on Osk1-173::GFP expression 
The osk mRNA contains a large 3ʼ UTR bound by many proteins 
implicated in activation or repression. To better reveal any regulatory defects 
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caused by loss of Bru dimerization, it would be ideal to monitor an mRNA 
regulated only by Bru, and thus free of potential sources of redundancy in 
regulation. For this purpose we used the UAS-osk1-173::GFP-AB reporter, which  
displays two regulatory features: Bru-dependent repression throughout the nurse 
cells and oocyte; and stage-dependent release from repression (or activation) in 
the oocyte. The latter effect is most dramatic for posterior-specific release from 
repression at stage 9, but there is also an overall increase in fluorescence 
throughout the oocyte beginning at stage 7/8.  
The osk1-173::GFP-AB reporter mRNA (Fig 2.13D) includes an osk 5' 
region, which encodes an anchoring domain (Vanzo and Ephrussi, 2002) and 
serves to restrict movement of the protein (and thus reveals where it is 
translated), and the osk 3' UTR AB region, which contains Bru binding sites and 
mediates Bru-dependent translational repression (Kim-Ha et al., 1995; Reveal et 
al., 2011). For the experiments described below, expression of the reporter 
mRNA was driven by the matα4-GAL-VP16 driver (Martin and St. Johnston, 
2003).  
In the aret+ background at stages 9 and 10, most egg chambers have 
Osk1-173::GFP in a gradient emanating from posterior of the oocyte (Fig 2.13A, 
Table 2.2). In the aretala background, the intensity of Osk1-173::GFP in the 
gradient was as strong as, or sometimes stronger, than for aret+ (Fig 2.13B), and 
the fraction of egg chambers showing the gradient was higher (Table 2.2). In the 
aretglu background, the Osk1-173::GFP gradient was frequently weaker than for 
aret+ (Fig 2.13C), and most egg chambers had no detectable gradient (Table 
2.2). These results were unexpected, since loss of Bru dimerization is predicted 
to interfere with repression (see Discussion). Instead, the results show that the 
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mutant unable to dimerize is defective in posterior expression, which could be 
due to enhancement or unnatural persistence of Bru-dependent repression, or to 
loss of Bru-dependent activation of translation.  
The S4E/S7E/T135E mutations impair Cup binding and eliminate 
dimerization in vitro but do not cause any detectable loss of translational 
repression in vivo. These interactions underlie the current models for translational 
repression by Bru, and two general explanations can account for the apparent 
discrepancy. First, one or both models may be wrong. Second, the mutations in 
Bru may have a stronger defect on in vitro protein interactions than on in vivo 
interactions. In particular, the Bru-Cup interaction is only partially defective in 
vitro, and might be stabilized or enhanced by other factors in vivo. To address the 
latter option, we wanted to test the two interactions - Bru-Bru and Bru-Cup - in 
vivo. Bru dimerization has not previously been detected in vivo. In an attempt to 
detect this interaction, we made use of flies expressing a Bru::GFP or GFP::Bru 
fusion protein. Immunoprecipitates obtained with anti-GFP antibodies were tested 
for the presence of Bru. Although Bru::GFP (Fig 2.14A) or GFP::Bru (Fig 2.14B) 
were readily detected with anti-Bru antibodies, Bru was not. We do not know why 
dimerization in vivo is not detected, but difficulty in detecting such an interaction 
limits our ability to test the Bru mutants.  
By contrast, Bru and Cup can be coimmunoprecipitated. Assays with 
extracts from the aret+ and aret-mutant ovaries revealed that each of the mutants 
retained a robust interaction with Cup (Fig 2.14C).  
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DISCUSSION 
Translational regulation of osk mRNA is critical for development. 
Repression of translation ensures that the protein does not accumulate where it 
could disrupt embryonic patterning. Activation of translation, coordinated with 
localization of the mRNA, provides a local source of Osk protein for posterior 
patterning and germ cell formation. Multiple factors are implicated in this 
regulation. Some provide specificity, binding selectively to the mRNA (Kim-Ha et 
al., 1995; Gunkel et al., 1998; Munro et al., 2006; Besse et al., 2009; Reveal et 
al., 2010; Vazquez-Pianzola et al., 2011). Others, the effector factors, are 
recruited by the specificity factors and function to interact or interfere with the 
translation machinery (Nakamura et al., 2001; Castagnetti and Ephrussi, 2003; 
Nakamura et al., 2004). The best characterized of the specificity factors is Bru, 
with well-defined binding sites (Kim-Ha et al., 1995; Reveal et al., 2011), 
compelling evidence of a role in repression (Lie and Macdonald, 1999; 
Castagnetti et al., 2000), and proposed models for how it mediates repression 
(Nakamura et al., 2004; Chekulaeva et al., 2006). In addition, Bru is also 
implicated in activation of translation (Reveal et al., 2010).  
Here we have characterized Bru protein interactions. Binding to the 
effector factor Cup is key to one model of repression, and Bru dimerization offers 
an explanation for how Bru could oligomerize osk mRNA in the other model of 
repression. We have also shown that Bru is phosphorylated in vivo, and have 
characterized phosphorylation of Bru in vitro by PKA. Although we have not been 
able to confirm that PKA performs the same phosphorylation in vivo, the Bru 
mutants used to map sites of PKA phosphorylation are valuable tools for 
interfering with Bru interactions via subtle changes in the protein.  
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Prior work with in vivo assays of Bru function has been limited to use of 
mutants obtained by classical forward genetic screens, as well as overexpression 
studies. The ability to introduce engineered mutations was constrained by the 
large size of aret (the gene encoding Bru), and the size restrictions of standard 
methods of transgenesis. We developed two types of assay systems to study, in 
vivo, the effects of mutations that disrupt Bru protein interactions. The first of 
these is the tethering assay, in which Bru is targeted to a reporter mRNA. 
Because the RNA-binding activity of Bru itself is dispensable in this assay, we 
could include mutations in the Bru RNA-binding domains. This reduces or 
eliminates Bru binding to mRNAs other than the reporter, and thus abrogates the 
developmental defects, which are caused by ectopic Bru expression, that 
complicate interpretation of results of such experiments (Filardo and Ephrussi, 
2003; Snee et al., 2008). A notable feature of this assay is that it showed two 
effects of Bru binding: translational repression and reduced mRNA stability. 
Although Bru can repress translation in ovary extracts with no effect on mRNA 
stability (Lie and Macdonald, 1999), regulation by Cup does alter mRNA stability 
(Igreja and Izaurralde, 2011). Therefore, when Bru recruits Cup to an mRNA, 
some reduction of mRNA stability is expected.  
The second general type of assay systems involved homologous 
recombination to introduce engineered mutations into the aret locus. These novel 
alleles can be used to study osk in its native context, as well as the osk 
transgenes modified to facilitate detection but under all of the normal 
transcriptional and post-transcriptional regulation. Because of the complexity of 
osk regulation, with extensive opportunities for redundancy, we also developed 
an mRNA substrate, osk1-173::GFP-AB, whose regulation predominantly or 
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exclusively relies on Bru as a specificity factor. By using a version of GFP fused 
to the Osk protein-anchoring domain, the movement of the protein was restricted, 
thereby revealing where it was translated. Strikingly, we found that translational 
repression of this mRNA was specifically alleviated at the posterior of the oocyte, 
independent of mRNA localization. Because the Osk1-173::GFP fusion protein 
does not itself migrate to the posterior of the oocyte, its appearance there must 
be due to local translation. This strongly argues that it is not the process of 
mRNA localization that is coordinated with this form of activation of translation, it 
is simply the outcome of the process that matters: mRNA at the posterior is more 
efficiently translated than mRNA at other positions.  
Using each of these assays we asked what happens when Bru has the 
three amino-acid changes, in the amino-terminal domain, that disrupt 
dimerization and reduce binding to Cup in vitro. Consistently, there was no 
substantial reduction in translational repression, a result seemingly at odds with 
both models proposed for repression. However, despite the reduction in Cup 
binding in vitro, the mutant Bru retained a sufficiently strong interaction with Cup 
in vivo to allow coimmunoprecipitation. It is possible that other ovarian proteins, 
not present in the in vitro binding assays, stabilize or enhance the Bru-Cup 
interaction in vivo.  
A more intriguing result was obtained with the osk1-173::GFP-AB reporter 
mRNA, which allows us to monitor regulation with Bru as the only, or 
predominant, specificity factor and thus independent of other forms of control. In 
the aret+ background, translation of Osk1-173::GFP was strongly repressed in 
the nurse cells and the oocyte, but with release from repression (or initiation of 
activation) specifically at the posterior of the oocyte beginning around stage 9 
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(coincident with the onset of productive osk mRNA translation). By contrast, the 
Bru mutant defective in protein interactions, aretglu, showed greatly reduced 
posterior expression. A provocative aspect of our results is the different 
consequences of mutations in Bru that either mimic or would prevent 
phosphorylation: while the phosphomimetic mutant (aretglu) had greatly reduced 
posterior Osk1-173::GFP, the mutant resistant to phosphorylation (aretala) 
showed enhanced posterior Osk1-173::GFP. As noted earlier, we have been 
unable to confirm that the affected Bru amino acids are bona fide sites for 
phosphorylation in vivo. Nevertheless, obtaining opposite results from mimicking 
or preventing phosphorylation does suggest that this modification occurs in vivo, 
and that the modification serves to inhibit activation or maintain Bru in a 
repressive form. Although PKA, the kinase that phosphorylates the amino-
terminal domain of Bru in vitro, has been implicated in enhancing Osk 
expression, while the Bru phosphomimetic mutant interferes with translation, 
PKA could have multiple effects on the pathways involved in regulation of osk. 
Alternatively, it may be that a different kinase phosphorylates Bru in vivo, or PKA 
phosphorylation of additional sites is specifically involved in activation.  
We propose a model for the posterior-specific switch in Bru-mediated 
repression based on the properties of the aret mutants. In the model, 
dimerization of Bru makes the protein competent for translational activation, 
either by inhibiting the repressive activity or converting it to an activator. The 
model is based on control of dimerization, since the phosphomimetic mutations 
most strongly affect that interaction, but control of other interactions (e.g. with an 
as yet uncharacterized binding partner) is possible. Phosphorylation of Bru 
inhibits dimerization, and helps maintain Bru in the repressive state. Reduced 
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phosphorylation of Bru, which we hypothesize occurs preferentially at the 
posterior of the oocyte starting at stage 9, alters the activity of Bru. With the 
phosphomimetic mutant, Bru is fixed in the repressive state, and the reporter 
regulated only by Bru has weakened posterior activation. The same is not true for 
osk mRNA, as forms of translational activation mediated by other specificity 
factors (Gunkel et al., 1998; Munro et al., 2006; Vazquez-Pianzola et al., 2011) 
contribute to expression. With the phosphosilent mutant, phosphorylation is 
prevented, enhancing activation of the reporter for which Bru is the only 
specificity factor. Because this mRNA is not translated throughout the egg 
chamber, there must be other regulatory factors, acting in concert with Bru for 
activation, which are limiting and perhaps restricted in their distribution.  
 
MATERIALS AND METHODS 
Flies and Transgenes 
w1118 flies were used as the wild type. Transgenic fly stocks were 
established by standard methods. Expression of the UAS transgenes was driven 
by the nosGAL4VP16 (Van Doren et al., 1998) or matα4-GAL-VP16 driver 
(Martin and St. Johnston, 2003), as indicated. The P[UAS-GFP-MS218] and 
P[UAS-GFP-boxB6] transgenes were generated by first inserting mGFP6 
(Haseloff, 1999) into the Asp718 site of pUASp (Rorth, 1998). Then 18 copies of 
the MS2 binding sites from p8486 or 6 copies of the boxB binding sites from 
p8918 were inserted as BamHI-BglII fragment into the BamHI site from the 
pUASp vector.  
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P[UAS-MCP::HA3::bru2-3-] was generated in multiple steps. First, a short 
5ʼ UTR and the coding sequence of the MCP gene were amplified by PCR to 
introduce terminal restriction sites, Asp718 (5ʼ) and BamHI (3ʼ) in frame. This 
Asp718-BamHI fragment was inserted into the pUASp vector using the same 
restriction sites. Then three copies of the HA epitope tag bearing BglII (5ʼ) and 
BamHI (3ʼ) at termini were inserted into the BamHI site from the pUASp vector, 
creating P[UAS-MCP::HA3]. Finally, the full-length or partially deleted bru cDNA 
that are bearing point mutations in RRM2 (K239A, F241A) and RRM3 (N521A, 
F523A) (Snee et al., 2008) was cloned into the BamHI (5ʼ) and XbaI (3ʼ) sites as 
either BglII-XbaI (full length and Δ334-416) or BamHI-XbaI (Δ1-146 and Δ1-146 
Δ334-416) fragment. Deleting the BamHI-XbaI fragment from P[UAS-
MCP::HA3::bru2-3-] made P[UAS-MCP::HA3::bru2-3-, 1-146]. P[UAS-
λN::HA3::bru2-3-] was generated by Paul Macdonald.  
The P[UAS-osk1-173::GFP-AB] transgene was generated by Ginny Pai. 
P[osk::HA3] and P[osk::GFP] were constructed by Paul Macdonald and both 
transgenes rescue the osk RNA-null phenotype but only osk::HA rescues the 
protein-null phenotype. osk0 was made by Brittany Marches via a modified ends-
out targeting. osk0 was recombined with P[osk::HA3] or P[osk::GFP] to keep the 
correct dosage of osk.  
Point mutations in the in silico PKA phosphorylation sites were 
independently made by site-directed mutagenesis within the 5ʼ region of the bru 
cDNA, which encodes Bru 1-146, and bearing BglII (5ʼ) introduced by PCR and 
internal BamHI (3ʼ) at termini. The BglII-BamHI fragment of bru was then inserted 
into the BamHI site in P[UAS-MCP::HA3::bru2-3-, Δ1-146] to make various full-
length MCP::HA3::Bru2-3- proteins bearing different point mutations.  
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Cloning, Expression and Purification of Recombinant Bru and Cup Proteins 
GST::Bru was constructed by subcloning full-length bru cDNA into pGEX-
2TK (GE Healthcare). GST::Cup577-947 was a gift from Robin Wharton (Verrotti 
and Wharton, 2000). The Bru proteins used for binding were tagged at the amino 
terminus with six histidine residues provided by the pET-15b (Novagen) vector 
and used for purification. Internal BamHI site and the EcoRI site in the 3ʼ UTR 
were used to make Δ1-146. Deleting the PflM1-NotI or BamHI-EcoRI fragment 
from the full-length bru cDNA made Δ334-416 or 1-146, respectively.  
Point mutations in the in silico PKA phosphorylation sites were 
independently made by site-directed mutagenesis within the 5ʼ region of the bru 
cDNA, which encodes 1-146, bearing NdeI (5ʼ) introduced by PCR and internal 
BamHI (3ʼ) at termini. NdeI-BamHI fragment was then replaced with equivalent 
fragment from either wild-type or Δ334-416 bru cDNA to make various full-length 
or Δ334-416 proteins bearing different point mutations.  
Proteins were expressed in CodonPlus (Stratagene) E. coli, after induction 
with IPTG. Pelleted cells were resuspended in ice-cold lysis buffer (50mM Tris-Cl 
pH8.0, 150mM NaCl, 1mM EDTA, 1mM DTT, 2mg/ml lysozyme, and 0.1% 
IGEPAL-CA-630) supplemented with Complete, Mini, EDTA-free protease 
inhibitor cocktail tablet (Roche). Following incubation on ice for 20 min, cells were 
lysed by sonication and lysates were centrifuged at 17,000g for 30 min at 4°C to 
remove debris. Glycerol was added to the supernatant to 20% final volume and 
the extracts were stored at -70°C.  
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A different buffer was used to make extracts for protein purification using 
the His6 tag. After induction, pelleted cells were resuspended in ice-cold lysis 
buffer (50mM NaH2PO4H2O pH8.0, 300mM NaCl, 20mM imidazole, 0.01% β-
Mercaptoethanol, and 2mg/ml lysozyme) supplemented with Complete, Mini, 
EDTA-free protease inhibitor cocktail tablet (Roche). Following incubation on ice 
for 20 min, cells were lysed by sonication and lysates were centrifuged at 
17,000g for 30 min at 4°C to remove debris. 250μl Ni-NTA Agarose (Quiagen) in 
50% slurry was added per 1ml supernatant, and the reaction was incubated for 1-
2 hr at 4°C on a rotator. The lysate-Ni-NTA mixture was then loaded into a 
disposable column equilibrated with the lysis buffer to remove flow-through and 
washed three times with increasing concentrations of imidazole in lysis buffer (up 
to 40mM). The proteins were eluted five times with 250mM imidazole in lysis 
buffer. Glycerol was added to the supernatant to 20% final volume and the 
extracts were stored at -70°C.  
 
GST Pull-down Assay 
Equivalent amount of GST::Bru, GST::Cup or GST was first immobilized 
on Glutathione Sepharose 4B (GE Healthcare) prepared in 50% slurry in binding 
buffer (50mM Tris-Cl pH7.5, 150mM NaCl, 10% glycerol, 1mM DTT, and 0.1% 
IGEPAL-CA-630) supplemented with Complete, Mini, EDTA-free protease 
inhibitor cocktail tablet (Roche), by incubating with the extract overnight at 4°C on 
a rotator. The beads were spun down, washed three times and resuspended in 
binding buffer to make 50% slurry. Then 20μl of this slurry was incubated with 
~100ng of each of the N-terminally His6-tagged Bru proteins in 80μl reaction 
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containing binding buffer for 2-3 hr at room temperature with rotation. The beads 
were spun down, washed three times with binding buffer, and boiled in 5μl 2X 
SDS loading buffer to elute the bound proteins. Eluates were separated by SDS-
PAGE and analyzed by Western blot. The mouse anti-His antibody (ABGENT) 
diluted at 1:2000 and alkaline phosphatase-conjugated goat anti-mouse antibody 
(Applied Biosystems) diluted at 1:5000 were used to detect Bru proteins.  
 
In Vitro Phosphorylation Assay 
Phosphorylation reactions (20μl) contained ~250ng of purified substrate, 
1-2 unit of recombinant PKA catalytic subunit, CK1 or CaMKII (all from NEB), and 
0.2mM [γ-32P]ATP (adjusted to 250μCi/μmol, Perkin Elmer) in kinase buffer 
(buffer for PKA: 50mM Tris-Cl pH7.5, 100mM KCl, 5mM MgCl2, and 2.4mM DTT; 
buffers for CK1 or CaMKII provided by NEB) supplemented with Complete, Mini, 
EDTA-free protease inhibitor cocktail tablet (Roche). Reactions were incubated at 
30°C for 30 min and terminated by addition of 3X SDS loading buffer. Proteins 
were separated by SDS-PAGE, and gels were dried (Bio-Rad) and exposed to a 
Phosphor Screen (Molecular Dynamics) for 12 hr. The screen was then analyzed 
with a Typhoon laser scanner (GE Healthcare).  
 
RNA Binding Assay 
The osk 3ʼ UTR AB probe was transcribed from p8391 using MAXIscript 
Kit (Ambion) and uniformly labeled with [α-32P]UTP (800Ci/mmol, Perkin Elmer). 
After phenol/chloroform extraction, unincorporated nucleotides were removed 
using NucAway spin column (Ambion) and the probe was precipitated with 
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ammonium acetate/ethanol. UV cross-linking assay was performed as described 
(Kim-Ha et al., 1995), except that 10X binding buffer consisted of 60mM Hepes 
pH7.9, 300mM KCl and 20mM MgCl2, and was supplemented with Complete, 
Mini, EDTA-free protease inhibitor cocktail tablet (Roche). ~500ng of purified 
recombinant Bru proteins were used. After electrophoresis of cross-linked 
adducts, gels were dried (Bio-Rad) and exposed to a Phosphor Screen 
(Molecular Dynamics) for 12 hr. The screen was then analyzed with a Typhoon 
laser scanner (GE Healthcare).  
 
RNase Protection Assay 
Ovaries from young females fed on yeast for 3-4 days were dissected into 
ice-cold PBS and RNA samples prepared using Tri Reagent-LS (Molecular 
Research Center) according to the manufacturerʼs instruction. Assays were 
performed using the RPA III kit (Ambion) according to the manufacturerʼs 
instruction and the results quantitated using ImageJ. Probes were transcribed in 
vitro using the MAXIscript Kit (Ambion) and uniformly labeled with [α-32P]UTP 
(800Ci/mmol, Perkin Elmer). Unincorporated nucleotides were removed using 
NucAway spin column (Ambion). After electrophoresis of probes, the gel was 
transferred to filter paper, covered with plastic wrap and exposed to a Phosphor 
Screen (Molecular Dynamics) for at least 2 hr. The screen was then analyzed 
with a Typhoon laser scanner (GE Healthcare).  
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Detection of Phosphorylated Bruno in the Ovary 
Ovaries from young females, fed on yeast for 3-4 days, were dissected 
and extract was prepared as previously described (Kim-Ha et al., 1995) in ice-
cold lysis buffer (50mM Hepes pH7.9, 150mM KCl, and 1% IGEPAL-CA-630) 
supplemented with Complete, Mini, EDTA-free protease inhibitor cocktail tablet 
(Roche). Reactions (20μl) contained 10-15μg of ovary extract in phosphatase 
buffer (50mM Hepes pH7.9, 100mM NaCl, 10mM MgCl2, and 1mM DTT), and 
where indicated, one or more of the following components were added: 1-2 units 
of alkaline phosphatase (calf intestinal, NEB), 1.6M beta-glycero phosphate, and 
40mM sodium vanadate. Reactions were incubated at 30°C for 1 hr and 
terminated by addition of 3X SDS loading buffer. Proteins were separated by 
SDS-PAGE and analyzed by Western blot.  
For phosphate-affinity SDS-PAGE using acrylamide-pendant Phos-tag 
(WAKO), 50μM Phos-tag and 200μM MnCl2 were added to both stacking and 
separating gels in solution.  
The mouse anti-Bru antibody (from Nakamura lab) diluted at 1:8000 and 
mouse anti-HA antibody (Covance) diluted at 1:1000 were used to detect 
endogenous and transgenic Bru proteins, respectively. The alkaline 
phosphatase-conjugated goat anti-mouse antibody (Applied Biosystems) diluted 
at 1:5000 was used together.  
 
Whole-Mount Ovary Staining 
Ovaries from young females fed on yeast for 3-4 days were dissected into 
PBS at room temperature and fixed in 4% formaldehyde in PBS for 20 min with 
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gentle mixing. The ovaries were then washed for 30 min in four changes of PBT 
(PBS plus 0.1% Triton X-100) and blocked for 2 hr in four changes of PBT 
containing 5% goat serum. For detection of GFP in situ, nuclei were 
counterstained with TO-PRO-3 Iodide (642/661, Invitrogen) diluted 1:1000 in PBT 
containing 1% goat serum for 1 hr at room temperature. For HA immunostaining, 
ovaries were incubated with anti-HA antibody (Covance) diluted 1:1000 in PBT 
containing 1% goat serum for 1-2 hr at room temperature, followed by an 
overnight rotation at 4°C. Ovaries were washed several times over 3 hr in PBT, 
then incubated with Alexa Fluor 488 goat anti-mouse antibody (Invitrogen) diluted 
1:800 and TO-PRO-3 Iodide (642/661, Invitrogen) diluted 1:1000 in PBT 
containing 1% goat serum for 2 hr at room temperature in dark. Finally, stained 
ovaries were washed several times over 3 hr in PBT and then mounted in 
Vectashield (Vector Labs). Microscopy of all samples made use of a Leica TCS-
SP laser scanning confocal microscope.  
Quantitation of GFP levels was done using the Macnification software from 
images obtained using a single plane of focus. The average green fluorescence 
was sampled from four different regions in the nurse cell cytoplasm of each of 10 
to 11, stage 5 or 6 egg chambers.  
 
Co-immunoprecipitation 
Ovaries from young females, fed on yeast for 3-4 days, were dissected 
and extract was prepared as previously described (Kim-Ha et al., 1995) except in 
ice-cold DXB-100 (25mM Hepes-K pH6.8, 250mM sucrose, 1mM MgCl2, 100mM 
KCl, 1mM DTT, and 0.1% Triton X-100) supplemented with Complete, Mini, 
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EDTA-free protease inhibitor cocktail tablet (Roche). To 1ml of 1mg lysate, 2μg 
of one of the following antibodies was added: rabbit anti-HA tag (Rockland), 
mouse anti-GFP (Santa Cruz), mouse anti-Bru (from Nakamura lab) and mouse 
anti-IgG (Santa Cruz). Reactions were incubated at 4°C overnight with rotation to 
form the immune complex. 13μl of Protein A/G Magnetic Beads (Pierce) was 
added to each reaction, followed by incubation at 4°C for 1-2 hr. Then the resin 
was washed three times with DXB-150 (same as DXB-100 except 150mM KCl). 
After adding 30μl of 2X SDS loading buffer to the resin, samples were vortexed, 
centrifuged and boiled. Proteins were separated by SDS-PAGE and analyzed by 
Western blot.  
The mouse anti-Bru antibody (from Nakamura lab) diluted at 1:8000 and 
mouse anti-HA antibody (Covance) diluted at 1:1000 were used to detect 
endogenous and transgenic Bru proteins, respectively, together with the alkaline 
phosphatase-conjugated goat anti-mouse antibody (Applied Biosystems) diluted 
at 1:5000. The rat anti-Cup219 antibody (from Smibert lab) diluted 1:2000 and 
the alkaline phosphatase-conjugated goat anti-rat antibody (Sigma) diluted at 
1:10,000 were used to detect Cup.  
 
Phosphopeptide Analysis of His6-Tagged Bruno 1-148  
Experimental: Trypsin in-gel digest was performed and followed by 
desalting with a µC18 ziptip (Millipore). The samples were run by LC-MS/MS on a 
Thermo Orbitrap Elite mass spectrometer equipped with an ultra-high-pressure 
Dionex Ultimate 3000 RSLC nano-LC system with buffer A (0.1% (v/v) formic 
acid in water) and buffer B (0.1% (v/v) formic acid in acetonitrile). Peptides were 
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concentrated onto an in-house packed 100-nm-inner diameter x 2-cm C18 
column (Magic C18, 3 µm, 100 Å, Michrom Bioresources Inc.), and then 
separated on a 75-nm-inner diameter x 15-cm C18 fused silica column (Dionex). 
Liquid chromatography was performed using a gradient of 3 to 27 to 45% buffer 
B over 0 to 69 to 80 min, with a total run time of 98 min. Data-dependent 
acquisition in the orbitrap detector used scan cycles of one MS1 scan (300-1700) 
at a resolution of 60,000 followed by MS2 at resolution 15,000 on the 10 most 
intense ions using CID fragmentation with 3 m/z isolation width and normalized 
collision energy of 35. Singly charged ions were excluded. Dynamic exclusion 
was used with 1 repeat count, 24 sec repeat duration, 12 sec exclusion duration 
and exclusion list of 500 ions. Technical replicates were performed for each 
sample.  
Peptide/protein identification was performed with ProteomeDiscoverer 1.4 
using search nodes SEQUEST_HT (Thermo) and MS-Amanda (Protein 
Chemistry Facility, Vienna, Austria, http://ms.imp.ac.at/?goto=pd-nodes). The 
initial search was conducted with SwissProt database (Jan 2014 version with 
456701 sequences) and the search parameters used were as follows: two 
missed cleavages were permitted, static modifications on cysteine 
carbamidomethylation, dynamic modifications on oxidized methionine, 10 ppm 
precursor tolerance and 0.02 Da MS/MS tolerance. Peptide identifications were 
filtered using the Target Decoy validation node where decoy database of 
reversed sequences is generated for calculating false discovery rates. A high 
confidence FDR 1% filtering was applied. The contaminant proteins were 
determined from the initial search, and then a custom database of 10-
contaminant trypsin and human keratin protein sequences, and the Bruno 
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sequence were concatenated with the E. coli database (from Jan 14, 2014) to 
create a custom database with 4963 sequences. The data was searched with the 
custom and a matched decoy database using the same parameters as before 
with the addition of dynamic modification of phosphorylation of serine and 
threonine and maximum 2 modifications/peptide. The search results were 
validated with the target decoy and, in parallel, routed to phosphoRS v. 3.0, 
where scores above 50 are considered good scores. PhosphoRS also assigns a 
probability for likelihood of a particular phosphorylation site on a given peptide on 
those peptide identifications made using SEQUEST HT. The results of all 
searches were filtered for high confidence peptides (FDR 1%), with 2 
peptides/protein.  
Results: Bruno was observed with 3657 spectral counts from the LC-
MS/MS runs searched with SEQUEST_HT and MS-Amanda, along with 27 
contaminant proteins having much lower spectral counts. Overexpressed Bruno 
with His6 tag had spectral counts covering 50% of the sequence. There is one 
sequence stretch not amenable to proteolytic digest, which was not observed, but 
all other peptides were observed with tens of spectral counts. Several 
phosphopeptides were observed with high confidence only in the kinase-treated 
sample. (6)ASFLANRR(13) was observed as a phosphopeptide in 3 spectral 
counts, and the site assignment of phosphorylation of S7 is unambiguous due to 
the single serine residue. The (6)ASFLANR(12) S7 phosphopeptide is also 
detected.  The peptides (-3)GSHMFTSRASFLANR(12) and (-
3)GSHMFTSRASFLANR(13) are also detected as phosphopeptides at high 
confidence. In this case the site assignment is ambiguous, with phosphoRS 
assigning equal probability for phosphorylation on T3, S4, and S7. Further 
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examination of the SEQUEST_HT results reveals that 8 of the 17 MS/MS have a 
higher XCorr value for the S7 site assignment than any other assignment, and 7 
have equivalent XCorr (scores differ by < 0.1) for the T3, S4 and S7 or the S4 
and S7 assignments, with the XCorr for all assignments shown in BrunoProtein 
sheet Bruno phosphopeptides. It is unclear how MS-Amanda site assignments 
are determined, so those spectral count site assignments are not included. Thus, 
the parsimonious explanation of the data restricts the assignment of 
phosphorylation to S7, though it does not rule out the possibility of 
phosphorylation of S4 and T3. In addition, at least 2 phosphorylation sites are 
detected on the 18-amino-acid, His-tag sequence in one or both samples.  
 
Genomic Engineering of the arrest Locus 
Since the entire aret locus is too big to target (over 100kb), we targeted a 
2.1kb region (12,270,445 to12,272,531; the gene annotation based on Release 
5.48) including the first two protein-coding exons that encode the amino terminus 
of female Bru (up to aa193). First the founder knock-out line was made by a 
modified ends-out targeting. The targeting donor DNA fragment contained 5ʼ and 
3ʼ homologous arms flanking the targeted region, and a loxP-flanked white+ (w+) 
transgenic marker juxtaposed by an attP site of ΦC31, as in pGX-attP (Huang et 
al., 2009). The 5ʼ arm (12,265,973 to 12,270,438) was made by PCR using the 
w1118 genomic DNA. The 4.5kb 5ʼ arm was cloned in three fragments into 
pCRII-TOPO vector (Invitrogen). The 5ʼ-most fragment was amplified to introduce 
a 5ʼ NotI site and included the KpnI site near the 3ʼ end. The middle fragment 
was amplified to include the KpnI near the 5ʼ end and the AflII near the 3ʼ end. 
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The 3ʼ-most fragment was amplified to introduce a 3ʼ KpnI site and included the 
AflII site near the 5ʼ end. Finally, these three fragments were ligated together into 
pGX-attP using NotI and KpnI within the 5ʼ MCS.  
The 3ʼ arm (12,272,538 to 12,276,637) was made by PCR using p4045 as 
a template. The plasmid was modified by converting XhoI at the 5ʼ end of the 3ʼ 
arm sequence into XbaI by cutting with XhoI, filling in the ends, and ligating with 
XbaI linker. Similarly, the plasmid was further modified by converting AflIII at the 
3ʼ end of the 3ʼ arm sequence into BamHI. Then the XbaI-BamHI fragment was 
cloned into pGX-attP using SpeI and BglII within the 3ʼ MCS.  
Transgenic stocks were established by standard methods. Virgins carrying 
the targeting donor DNA were crossed to males carrying hs-flp and hs-ISceI 
(Bloomington 6935), and the resulting progeny were heat-shocked three times 
over three days as embryos. Many mosaic-eyed progeny were obtained, 
indicating ends-out targeting worked. Then the mosaic-eyed virgins were again 
crossed to males carrying P{70flp}10 (Bloomington 6938) in order to reduce the 
number of false positives. The resulting progeny were heat-shocked once three 
days later as embryos. Red-eyed males were selected and balanced over CyO 
chromosome after segregation testing. Homozygous females were sterile, as 
expected for aret phenotype. Deletion was further verified by PCR.  
The w+ marker in between the 5ʼ and 3ʼ arms was removed by crossing 
the knock-out males to virgins carrying hs-Cre (Bloomington 1092). There was no 
heat shock involved because Cre was supposed to be constitutively active. The 
desired progeny, which have the knock-out chromosome and hs-Cre-bearing 
chromosome, were orange-eyed due to the marker present in hs-Cre. The 
orange-eyed males were then crossed to virgins carrying vasa-ΦC31 
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(Bloomington 24749). Balanced stocks were established from a single male and 
sent for injection with various replacement plasmids in pGE-attB vector. The w+ 
marker and extra vector sequences were removed by Cre recombinase, as 
described above, and balanced stocks were established from a single male. 
Correct integration and presence of appropriate mutations were verified by PCR.  
To produce aret mutants containing triple ala or glu mutations, we 
performed site-directed mutagenesis with two rounds of PCR for each of S4/S7 
and T135 mutations. Each of the two PCR fragments were synthesized in the first 
PCR reaction using a mutagenic primer, a primer that anneals to either the 5ʼ or 
3ʼ end of the replacement DNA, and w1118 DNA as the template. Terminal 
restriction sites, EcoRI (5ʼ) and KpnI (3ʼ), were introduced. The two PCR 
fragments were purified, and a second PCR was performed using a mix of these 
two fragments and the two terminal primers used previously. The final 
mutagenized PCR fragment (~2.1kb) was first cloned into pCRII-TOPO, and 
EcoRI-KpnI fragment was subcloned into pSP73. Internal EcoRV site 
(12,271,334) was used to cut out and ligate the 5ʼ EcoRI-EcoRV fragment 
carrying S4/S7 mutation, and the 3ʼ EcoRV-KpnI fragment carrying T135 
mutation, into pGE-attB vector using EcoRI and KpnI.  
All PCR reactions were carried out using Phusion High-Fidelity PCR 
Master Mix (Finnzymes) to minimize the error rate.  
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FIGURES 
 
Figure 2.1. Bru dimerizes and Bru domain 1-146 is important for Cup 
binding 
(A) GST pull-down assays using GST::Bru or GST, and the full-length Bru 
protein. Left panel is a Western blot probed with anti-His6 antibody, which detects 
Bru (but not GST::Bru). Right panel is a Coomassie staining of GST::Bru and 
GST to show the amounts used for the experiment.  
(B) GST pull-down assays using GST::Cup or GST, and the Bru proteins as 
labeled. Each panel is a Western blot probed with anti-His6 antibody, which 
detects the Bru proteins (but not GST::Bru).  
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Figure 2.2. Bru domain 1-146 is important for both Bru and Cup binding 
(A) GST pull-down assays using the GST fusion proteins indicated at top, and the 
purified Bru proteins as labeled. Each panel is a Western blot probed with anti-
His6 antibody, which detects the Bru proteins (but not GST::Bru).  
(B) A schematic diagram of Bru proteins used in part A. The three RNA 
Recognition Motifs (RRMs) of Bru are shown as gray boxes; RRM3 is an 
extended RRM and is thus larger (Lyon et al., 2009). A summary of results from 
the pull-down experiments is shown on the right. ++++ indicates a wild-type level 
 
Fig.  1.  Bru  domain  1-­146  is  involved  in  b th  Cup  and  Bru  binding.
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of binding, - is no detectable binding, and the intermediate values indicate the 
relative strengths of impaired binding.  
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Figure 2.3. Levels of tethered Bru proteins and GFP-MS2 reporter RNA in 
ovaries  
(A and B) Western blot of ovary extract from flies expressing MCP::HA3::Bru 
proteins as labeled. Expression of the UAS transgenes was driven by the matα4-
GAL-VP16 driver (Martin and St. Johnston, 2003). Proteins were detected using 
anti-HA antibody.   
(C) RNase protection assays of GFP-MS2 and rp49 mRNAs from ovaries 
expressing MCP::HA3::Bru proteins as labeled. Expression of the UAS 
transgenes was driven by the nosGAL4VP16 driver (Van Doren et al., 1998). 
Quantitation of the RNA levels is shown on Fig 2.4L.  
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Figure 2.4. The Bru amino-terminal domain is essential for translational 
repression in a tethering assay 
 
Fig.  2.  Bru  N-­term  domain  is  important  for  repressing  translation  of  the  GFP  reporter
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(A-C, Aʼ-Cʼ) show egg chambers expressing the GFP-MS2 reporter mRNA. (B-C, 
Bʼ-Cʼ) also express either MCP::HA3::λN (B, Bʼ) or MCP::HA3::Bru+ (C, Cʼ) 
protein. All Bru proteins used include point mutations in RRM2 and RRM3 to 
inhibit the Bruʼs RNA-binding activity (this has no effect on tethering, which relies 
on the MCPʼs RNA-binding activity). Ectopic expression of Bru causes 
developmental defects early in oogenesis (Filardo and Ephrussi, 2003; Snee et 
al., 2008), which would complicate the assay. By inhibiting Bruʼs RNA binding, 
these defects are eliminated (Snee et al., 2008). (A-C, Aʼ-Cʼ) were fixed in 
parallel and imaged together under the same settings. A phage lambda N protein 
fused to MCP did not render repression of the reporter but rather caused 
elevated GFP level (panel B), partly due to an increase in the GFP-MS2 RNA 
level (Fig 2.3C).  
 (D-I, Dʼ-Iʼ) show egg chambers expressing the GFP-MS2 reporter mRNA. (E-I, 
Eʼ-Iʼ) also express MCP::HA3::Bru proteins, of the type shown at left. (D-I, Dʼ-Iʼ) 
were fixed in parallel and imaged together under the same settings. Expression 
of the UAS transgenes was driven by the nosGAL4VP16 driver (Van Doren et al., 
1998).  
 (J) GFP fluorescence was quantitated using Macnification and the value for 
none, which lacks any MCP::HA3::Bru proteins, was set to one. The mean and 
standard deviation were calculated from roughly 40 samples per genotype. The 
asterisks indicate the Bru proteins with the GFP protein level differing significantly 
from the Bru+, using the studentʼs T test (*p≤0.05, **p≤0.01, ***p≤0.001).  
 (K) GFP fluorescence was normalized for the GFP-MS2 RNA levels, which were 
normalized using the rp49 RNA levels as in panel (L). The value for none, which 
lacks any MCP::HA3::Bru proteins, was set to one. The mean and standard 
 78 
deviation were calculated from roughly 40 samples per genotype. The asterisks 
indicate the Bru proteins with the GFP protein/RNA level differing significantly 
from the Bru+, using the studentʼs T test (*p≤0.05, **p≤0.01, ***p≤0.001).  
 (L) GFP-MS2 RNA levels in Fig 2.3C were quantified by ImageJ and normalized 
using the rp49 signal. The value for none, which lacks any MCP::HA3::Bru 
proteins, was set to one.  
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Figure 2.5. PKA phosphorylates Bru in the amino-terminal domain and Bru 
phosphosilent mutations disrupt phosphorylation by PKA 
(A) (Left) Western blot of wild-type ovary extract after incubation with 
phosphatase and/or phosphatase inhibitors as indicated above. Proteins were 
detected using anti-Bru antibody. (Right) Western blot of ovary extract from flies 
expressing MCP::HA3::Bru1-146 protein, with treatments noted as above. 
Proteins were detected using anti-HA antibody. Inhibitors used were sodium 
vanadate and beta-glycero phosphate, which are competitive inhibitors of the 
alkaline phosphatase.  
 (B) In vitro phosphorylation assay using gamma 32P-ATP, purified mouse PKA 
catalytic subunit and purified Bru proteins as labeled (as in Fig 2.2B). BSA was 
 
Fig.  3.  PKA   hosphorylates  Bru  in  the  N-­term  domain  and  Bru  phospho-­silent  mutations  
additively  disrupt  phosphorylation  by  PKA.
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used as a negative control. Top: autoradiogram to detect phosphorylation. 
Bottom: Coomassie staining of proteins used for the phosphorylation assay to 
show the relative amounts of input proteins. The upper band in 1-146 lane is a 
contaminating bacterial protein.  
 (C) In vitro phosphorylation assay using gamma 32P-ATP, purified mouse PKA 
catalytic subunit and purified phosphosilent (Ala) mutant Bru proteins as labeled. 
The positions of amino acids predicted to be candidates for phosphorylation by 
PKA are shown in the schematic (D). The point-mutated Bru proteins have the 
Δ334-416 deletion, which does not affect phosphorylation (panel B). Top: 
autoradiogram to detect phosphorylation. A similar assay using the same 
mutations in the context of the full-length Bru is shown in Fig 2.6B. Bottom: 
Western blot of proteins used in the phosphorylation assay to show the relative 
amounts of input proteins.  
 (D) A schematic diagram of Bru showing PKA phosphorylation sites predicted by 
NetPhosK and KinasePhos. Three amino acids, S4, S7 and T135, depicted as 
black circles, were tested in different experiments by mutating them to either 
alanine (phosphosilent) or glutamate (phosphomimetic).  
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Figure 2.6. Bru is phosphorylated at multiple sites and Bru phosphosilent 
mutations disrupt phosphorylation by PKA 
(A) Phosphate-affinity SDS-PAGE using acrylamide-pendant Phos-tag that 
separates different phosphoprotein isoforms, followed by Western blot to detect 
proteins using anti-Bru antibody. When the wild-type ovary extract is treated with 
phosphatase alone, a major Bru band and two upper bands, of which one more 
distinct and running higher than the other, are seen. When inhibitors are also 
present, there is a visible smudge consisting of multiple bands above the major 
Bru band. Inhibitors used were sodium vanadate and beta-glycero phosphate, 
which are competitive inhibitors of the alkaline phosphatase.  
 (B) In vitro phosphorylation assay using gamma 32P-ATP, purified mouse PKA 
catalytic subunit and purified phosphosilent (Ala) mutant Bru proteins as labeled. 
The positions of amino acids predicted to be candidates for phosphorylation by 
PKA are shown in the schematic Fig 2.5D. The Bru proteins are full length and 
used at concentrations less than the Δ334-416 Bru proteins in Fig 2.5C. Top: 
autoradiogram to detect phosphorylation and show that compared to Bru+, S7A 
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mutant has reduced phosphorylation. Phosphorylation of both S4A/S7A and 
S4A/S7A/T135A mutants is undetectable as with Δ1-146. Bottom: Western blot 
of proteins used in the phosphorylation assay to show the relative amounts of 
input proteins.  
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Figure 2.7. Bru is phosphorylated by PKA but not by CK1 or CaMKII 
(A) In vitro phosphorylation assay using gamma 32P-ATP, purified mouse PKA 
catalytic subunit, and purified Bru or BSA. The amount of substrates used was 
equivalent, but a lot higher than that shown in Fig 2.5B. The autoradiogram 
shows that compared to BSA, Bru+ is strongly phosphorylated.  
 (B) In vitro phosphorylation assay using gamma 32P-ATP, purified rat CK1 (top) 
or purified rat CaMKII (middle), and purified Bru proteins as labeled. Top and 
middle: autoradiograms to detect phosphorylation. Both Δ334-416 and Δ1-146 
Δ334-416 proteins show a low amount of phosphorylation by CK1. Bottom: 
Western blot of proteins used in the phosphorylation assay to show the relative 
amounts of input proteins. The amount of Bru+ used was equivalent in both 
panels.  
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Figure 2.8. Bru phosphomimetic mutations additively impair both Bru-Cup 
and Bru-Bru interactions 
 
Fig.  4.  Bru  phospho-­mimetic  mutations  additively  disrupt  both  Bru-­Cup  and  Bru-­Bru  interactions
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GST::Bru (A) and GST::Cup (B) pull-down assays to detect interactions with Bru 
proteins. The input proteins are indicated at top, with Δ1-146 Δ334-416 as a 
negative control. Each panel is a Western blot probed with anti-His6 antibody, 
which detects the Bru proteins (but not GST::Bru).  
 (C) A summary of results from the pull-down assay. ++++ indicates a wild-type 
level of binding, - is no detectable binding, and the intermediate values indicate 
the relative strengths of impaired binding.  
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Figure 2.9. Bru phosphomimetic mutations impair Bruʼs osk RNA-binding 
activity 
(A) UV-crosslinking assay of Bru binding to the radiolabeled osk 3' UTR AB 
region RNA. The Bru proteins used are indicated above the autoradiogram 
showing crosslinked Bru. At bottom is a Western blot of input proteins showing 
the relative amounts used in the assay.  
 (B) The osk RNA-binding activity and Bru protein levels were quantitated using 
ImageJ. The RNA binding was normalized for the protein level, and the value for 
Bru+ was set to one. The mean and SEM were calculated from three 
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independent experiments. The change in RNA-binding activity in a pair-wise 
comparison was considered significant in S4/S7 and S4/S7/T135 using the 
studentʼs T test (*p≤0.05; **p≤0.01). The change in RNA binding of S4E/S7E 
(26% from the ala counterpart with p=0.008) was considered more statistically 
significant than that of S4E/S7E/T135E (40% decrease from the ala counterpart 
with p=0.04), due to a greater sample variation of S4/S7/T135.  
  
 88 
Figure 2.10. Interaction-
defective Bru mutants retain 
strong repressive activity in the 
tethering assay 
(A-G, Aʼ-Gʼ) show egg chambers 
expressing the GFP-MS2 reporter 
mRNA. (B-G, Bʼ-Gʼ) also express 
MCP::HA3::Bru proteins, of the 
type shown at left. All Bru proteins 
include point mutations in RRM2 
and RRM3 to inhibit the Bruʼs 
RNA- binding activity (this has no 
effect on tethering, which relies on 
the MCPʼs RNA-binding activity). 
All samples were fixed in parallel 
and imaged together under the 
same settings. Expression of the 
UAS transgenes was driven by the 
nosGAL4VP16 driver (Van Doren 
et al., 1998).  
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Figure 2.11. Interaction-defective Bru mutants can repress translation of 
the GFP-boxB reporter in a tethering assay 
(A-C, Aʼ-Cʼ) show egg chambers expressing the GFP-boxB reporter mRNA. (B-C, 
Bʼ-Cʼ) also express λN::HA3::Bru proteins, of the type shown at left. All Bru 
proteins include point mutations in RRM2 and RRM3 to inhibit the Bruʼs RNA- 
binding activity (this has no effect on tethering, which relies on the λNʼs RNA-
binding activity). All samples were fixed in parallel and imaged together under the 
same settings. Expression of the UAS transgenes was driven by the matα4-GAL-
VP16 driver (Martin and St. Johnston, 2003). The levels of the MCP::Bru fusion 
proteins are expected to be similar since they were inserted at the same genomic 
location via ΦC31-mediated DNA integration, and the mutations in Bru did not 
alter Bru protein stability in the other tethering assay.  
 (D) GFP fluorescence was quantitated using Macnification. The mean was 
calculated from over 20 samples per genotype.  
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Figure 2.12. The Osk expression pattern in aret replacement lines 
 (A-F, Dʼ-Fʼ) show egg chambers expressing the osk::HA genomic transgene in 
different genetic backgrounds with a distinct, genetically engineered aret gene, 
as labeled. All have a single copy of aret in trans to Df(2L)aret and two copies of 
 
Fig  6.  Osk::HA  and  Osk::GFP  expression  pattern  in  bru  replacement  lines
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the osk transgene. (A-C) are stage 8, and (D-F) are stage 9 egg chambers. (Dʼ-
Fʼ) show HA in green and nuclei in red. All samples were fixed in parallel and 
imaged together under the same settings.  
 (G-I, Gʼ-Iʼ) show late-stage egg chambers expressing the osk::GFP genomic 
transgene in different genetic backgrounds with a distinct, genetically engineered 
aret gene, as labeled. All have a single copy of aret in trans to Df(2L)aret and two 
copies of the osk transgene. (Gʼ-Iʼ) show GFP in green and nuclei in red. All 
samples were fixed in parallel and imaged together under the same settings.  
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Figure 2.13. The osk1-173::GFP-AB reporter expression in aret 
replacement lines 
(A-C, Aʼ-Cʼ) show egg chambers expressing the osk1-173::GFP-AB reporter in 
different genetic backgrounds with a distinct, genetically engineered aret gene, 
as labeled. All have a single copy of aret in trans to Df(2L)aret and a single copy 
of the reporter. (Aʼ-Cʼ) show GFP in green and nuclei in red. All samples were 
fixed in parallel and imaged together under the same settings. Expression of the 
UAS transgene was driven by the matα4-GAL-VP16 driver (Martin and St. 
Johnston, 2003).  
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 (D) A schematic diagram of the UAS-osk1-173::GFP-AB reporter. The large 
rectangle comprises a part of the osk coding sequence including two start codons 
and up to T173 and a full GFP coding sequence as labeled. The osk 3' UTR AB 
region, which contains the BREs, is depicted as the small rectangle. The thick 
black line includes the 15nt 5ʼ UTR common to both Osk isoforms and 5ʼ UTR 
specific for the short isoform. The thick gray line is the 0.4kb K10 3ʼ UTR 
fragment, part of the pUASp vector sequence in gray (Rorth, 1998).  
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Figure 2.14. Bru amino-terminal mutations do not disrupt Cup binding in 
vivo 
(A) Immunoprecipitation from ovary extract expressing Bru::GFP using the 
antibodies as labeled. Each panel is a Western blot probed with anti-Bru 
antibody, which detects the Bru proteins. Expression of the UAS transgene was 
driven by the matα4-GAL-VP16 driver (Martin and St. Johnston, 2003).  
 (B) Immunoprecipitation from ovary extract expressing GFP::Bru using the 
antibodies as labeled. Each panel is a Western blot probed with anti-Bru 
antibody, which detects the Bru proteins. Expression of the UAS transgene was 
driven by the matα4-GAL-VP16 driver (Martin and St. Johnston, 2003).  
 (C) Immunoprecipitation from the wild-type (+) or genetically engineered aret 
ovary extracts as labeled, using the antibodies as labeled. All have a single copy 
of aret in trans to Df(2L)aret. Each panel is a Western blot probed with anti-Cup 
or anti-Bru antibody.  
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 TABLES 
 
Table 2.1. Embryonic development of various aret replacement lines 
a All have a single copy of aret in trans to Df(2L)aret, which removes much of 
aret and some of bru-2. aret+ is the wild-type replacement. Most of the 
replacement lines, when homozygous, showed maternal-effect lethality. This was 
not due to the aret mutations, since this phenotype was not present for 
hemizygotes. Consequently, all replacement lines used here and in other 
experiments were tested in a hemizygous background.  
b Embryos had either wild-type (with 8 abdominal denticle belts) or no cuticle.  
 
  
 
Table  1.  Embryonic  development  of  various  aret  replacement  lines
Maternal  Genotype Wild  Type
No  Cuticle
bCuticular  Phenotype  (%)
N
99 1 686
95 5 455
82 18 421
a   Development
aret    /Df(2L)aret+
aret        /Df(2L)aretala
aret        /Df(2L)aretglu
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Table 2.2. Expression of UAS-osk1-173::GFP-AB in various aret 
replacement lines 
a All have a single copy of aret in trans to Df(2L)aret, which removes much of 
aret and some of bru-2. aret+ is the wild-type replacement.  
b The number of stage 9/10 egg chambers displaying strong, weak or 
undetectable GFP signal was scored.  
 
 
Table  2.  Expression  of  UAS-­osk1-­173::GFP-­AB  in  various  aret  replacement  lines
bOocyte  GFP  level  (%)
Maternal  Genotype a Strong nWeak Undetectable
55 21 24 29
60 23 17 30
15 23 62 26
aret        /Df(2L)aret;;  UAS-­osk1-­173::GFP-­ABala
aret    /Df(2L)aret;;  UAS-­osk1-­173::GFP-­AB+
aret        /Df(2L)aret;;  UAS-­osk1-­173::GFP-­ABglu
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Chapter 3: Investigating the Role of PKA in Bruno-dependent 
Translational Regulation2 
 
ABSTRACT 
Translational control of localizing mRNAs is a common and an efficient 
way to restrict protein synthesis in cells. In Drosophila, several RNAs are 
localized to a distinct subcellular location within an oocyte and embryo to direct 
body patterning. Oskar (Osk) is a posterior-patterning determinant in Drosophila 
and is highly concentrated at the posterior pole of the oocyte. Tight spatial and 
temporal restriction of the Osk patterning activity is essential for proper 
development of the embryo. Bruno (Bru) directly binds to the osk mRNA and 
represses translation during mRNA localization to the posterior pole. After osk 
mRNA localization, repression must be alleviated to allow accumulation of Osk 
protein. How this is achieved is unclear, but local inactivation of repressors at the 
site of protein synthesis is an option that has been previously reported for 
localized mRNAs in other systems. cAMP-dependent protein kinase (PKA) is 
expressed in the ovary, and the loss-of-function mutants in the type 1 regulatory 
subunit (Pka-R1) are defective in repression of osk translation. Here we test the 
role of PKA on Bru phosphorylation and Bru-mediated repression. Altering PKA 
activity causes small, yet detectable changes in Bru phosphorylation and Bru-
dependent translational repression using an osk::GFP reporter bearing a Bru-
binding region. Notably, however, the changes detected by altering PKA activity 
                                            
2 Goheun Kim and Paul M. Macdonald, Department of Molecular Biosciences, Institute 
for Cellular and Molecular Biology, The University of Texas at Austin 
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are very different from those using Bru phosphomimetic and phosphosilent 
mutations. The reason for this difference is not known. PKA must phosphorylate 
many different proteins, with the potential for both direct and indirect effects on 
Bru and on osk regulation. 
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INTRODUCTION 
A vast number of mRNAs are localized to a specific subcellular location to 
establish functionally distinct compartments. Localizing mRNAs are also 
translationally regulated, such that they are repressed during transport and 
derepressed or activated upon localization (reviewed in Besse and Ephrussi, 
2008; Kugler and Lasko, 2009; Martin and Ephrussi, 2009). Localizing mRNAs 
function in a diverse set of cellular events such as epithelial cell polarity (Horne-
Badovinac and Bilder, 2008; Li et al., 2008), cell migration (Condeelis and Singer, 
2005), cell fate specification (Long et el., 1997; Lambert and Nagy, 2002; Kugler 
and Lasko, 2009), synaptic plasticity (Sutton and Schuman, 2006) and guidance 
of axonal growth cones (Lin and Holt, 2007). In addition to providing spatial 
restriction of gene expression, mRNA localization provides a high temporal 
resolution given that a local stimulus can induce protein synthesis on-site rather 
than a relatively delayed nuclear response (Martin and Ephrussi, 2009).    
Localizing mRNAs are packaged into Ribonucleoproteins (RNPs) 
containing trans-acting, RNA-binding proteins that bind cis-acting, regulatory 
elements in RNA and mediate localization and/or translational repression. RNA-
binding proteins that repress translation are often phosphorylated at the final 
destination by a pre-localized kinase or in response to a specific signal (Besse 
and Ephrussi, 2008). For example, Puf6 and Khd1 are proteins that bind the 
ASH1 mRNA and repress translation in budding yeast. Phosphorylation of Puf6 
by Ck2 (casein kinase-II) and Khd1 by Yck1 (type I casein kinase) reduce their 
RNA binding affinity for ASH1, leading to translational derepression (Paquin et 
al., 2007; Deng et al., 2008). Both Ck2 and Yck1 localize to the bud cortex where 
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ASH1 is translated. In neurons, translation of localized mRNAs occurs in 
response to specific external signals, such as synaptic activation and axonal 
guidance cues (Bramham and Wells, 2007; Lin and Holt, 2007). For instance, Glu 
stimulation induces Aurora kinase-dependent phosphorylation of CPEB, after 
which it switches from being a translation repressor to an activator of cytoplasmic 
polyadenylation element (CPE)-containing CAMKIIα target mRNA, by promoting 
elongation of the poly(A) tail (Huang et al., 2002).  
The oskar (osk) mRNA is transcribed in nurse cells and transported into 
the oocyte early in oogenesis (Ephrussi et al., 1991; Kim-Ha et al., 1991). Then 
the mRNA is localized to the posterior pole at stage 9 of oogenesis, when Osk 
protein is first made (Kim-Ha et al., 1995; Markussen et al., 1995; Rongo et al., 
1995). Usage of alternative start codons that are in the same reading frame 
within the coding sequence makes two Osk isoforms, which have distinct 
functions (Markussen et al., 1995). Long Osk is required for anchoring of osk 
RNA and Short Osk protein. Short Osk induces formation of the germ plasm 
containing determinants for both posterior patterning and germ cell formation 
(Markussen et al., 1995; Vanzo and Ephrussi, 2002).  
Translational repression of osk during transport is mediated by Bruno 
(Bru), which directly binds the osk 3ʼ UTR in two regions: AB close to the coding 
sequence and C close to the poly(A) tail. Each region contains multiple Bru-
binding sites, including the Bruno Response Elements (BREs) (Kim-Ha et al., 
1995; Reveal et al., 2011). Direct evidence for translational repression comes 
from in vitro assays using cell-free translation systems from ovary extract, which 
recapitulates Bru- and BRE-dependent repression (Lie and Macdonald, 1999; 
Castagnetti et al., 2000).  
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There are several cis elements important for translational activation of osk: 
BREs in the C region, Imp-binding elements (IBEs), and a 5ʼ activating element. 
Mutating the C region BREs causes defects in Osk accumulation and posterior 
patterning, implicating C region BREs in activation of translation, in addition to a 
redundant role in repression (Reveal et al., 2010). IBEs are motifs found in 
multiple copies within the osk 3ʼ UTR, and are binding sites for the Drosophila 
homolog of insulin growth factor II mRNA-binding protein (IMP). Mutating subsets 
of IBEs results in defects in Osk accumulation and posterior patterning, although 
Imp mutants have no defects in osk regulation (Geng and Macdonald, 2006; 
Munro et al., 2006). The 5ʼ activating element is a poorly characterized region 
within the coding sequence between the start codons for Long and Short Osk. 
Inversion of the 3ʼ half within this 130nt region abrogates binding of two ovarian 
proteins: p50, later identified as Hrp48; and p68, whose identity remains 
unknown (Gunkel et al., 1998; Yano et al., 2004). The effects of the inversion on 
expression was monitored using a lacZ reporter mRNA, which contains the osk 5ʼ 
region up to the downstream AUG for the Short Osk, fused to the lacZ coding 
sequence, followed by the entire osk 3ʼ UTR. In this reporter, the inversion 
mutation prevents posterior accumulation of the β-galactosidase activity (Gunkel 
et al., 1998). Although the 5' element and IBEs function in activation of 
translation, the trans-acting proteins that bind them to mediate activation are 
unknown. For the BREs in the C region, Bru is a candidate activator, which could 
switch its role from a repressor at the right time by recruiting other factors 
specifically to the C region to mediate activation.  
The cAMP-dependent protein kinase (PKA) is involved in many signaling 
events and is only transiently activated in response to cAMP. The PKA 
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holoenzyme complex is a tetramer composed of two catalytic subunits and a 
regulatory subunit dimer. The regulatory subunits bind the catalytic subunits to 
sequester them in an inactive state in the absence of cAMP. Upon binding cAMP, 
the regulatory subunits undergo a conformational change and release the 
catalytic subunits from inhibition (Taylor et al., 2004 and 2012). In Drosophila, 
there are two regulatory subunits (Pka-R1, Pka-R2; FlyBase) and three catalytic 
subunits (Pka-C1, Pka-C2, Pka-C3; FlyBase). DC0 (Pka-C1) is a Drosophila PKA 
gene that has the highest homology to the mammalian PKA, and measurement 
of the kinase activity in adult extracts showed that DC0 is the source of all or 
most cAMP-dependent kinase activity. DC0 is an essential gene and mutants are 
lethal. During oogenesis, loss of DC0 disrupts microtubule polarity, and the actin 
structures around ring canals that connect nurse cells (Lane and Kalderon, 
1993). Pka-R1-mutant ovaries that have increased catalytic activity show 
precocious and ectopic translation of Osk, and the resulting embryos have 
anterior patterning defects such as head defects and the bicaudal phenotype (a 
mirror-image duplication of abdominal segments), due to excess Osk activity 
(Yoshida et al., 2004). Translation of both short and long isoforms of Osk are 
increased although the mRNA level remains the same. Both PKA-C1 and PKA-
R1 proteins are enriched on the germ cell membranes but expression in follicle 
cells is also detectable (Lane and Kalderon, 1995; Yoshida et al., 2004).  
DC0 (Pka-C1) is required in the germline to establish correct microtubule 
polarity during mid oogenesis, during which the microtubule network undergoes a 
rearrangement prior to osk mRNA localization (Lane and Kalderon, 1994). 
Reorganization of microtubules requires two sequential signaling events between 
the oocyte and somatic follicle cells: from the oocyte to the follicle cells, and then 
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from the follicle cells back to the oocyte (González-Reyes et al., 1995; Roth et al., 
1995). Thus it has been postulated that PKA transduces a temporal signal from 
the posterior follicle cells for reorganization of the microtubule network (Lane and 
Kalderon, 1994; González-Reyes et al., 1995; Roth et al., 1995). It is also 
plausible that this temporal cue is responsible for local translation via 
phosphorylation of Bru or other regulators of osk. Interestingly, PKA 
phosphorylates Bru in vitro, and mutating the candidate sites of phosphorylation 
reduces the ability to be phosphorylated by PKA (see Chapter Two). Therefore, 
Bru could be one of the targets of PKA in the osk regulatory pathway, but it is 
unlikely to be the sole target since we did not see any patterning defects 
associated with osk regulation when the candidate sites were mutated (see 
Chapter Two).  
Here we investigate the role of PKA in Bru-dependent translational control 
using osk::GFP reporter mRNAs. We alter the catalytic activity by several 
approaches: using the Pka-R1 loss-of-function mutant, and using flies expressing 
constitutively active, regulatory (R*) or catalytic (C*) subunits. We find that 
altering PKA activity has no consistent detectable effect on Bru phosphorylation. 
Expression of an osk::GFP reporter mRNA, which is under Bru-mediated 
repression but shows oocyte-specific translation, is sensitive to an increase in 
PKA activity. Together, these results suggest that PKA is under a tight regulation, 
and a small change in the catalytic activity can lead to a substantial defect in osk 
regulation.   
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RESULTS 
Modulating PKA activity does not dramatically alter the amount of Bruno 
phosphorylation 
Increasing PKA catalytic activity causes a defect in translational 
repression of osk mRNA prior to its localization, and the resulting embryos are 
bicaudal (Yoshida et al., 2004). PKA activity can be modulated by mutating the 
regulatory or catalytic subunits. Yoshida et al. identified two strong loss-of-
function alleles of Pka-R1, Pka-R1E1 and Pka-R118304, through genetic screens 
and showed that extracts of mutant, adult flies displayed increased kinase activity 
as compared to wild-type (the increase was only 1.2 fold without addition of 
exogenous cAMP, but 1.5-2 fold with addition of 5μM cAMP). Similarly, 
transgenic expression of the constitutively active, catalytic subunit (C*), which 
bears mutations that render it insensitive to regulation by the regulatory subunit 
(Orellana and McKnight, 1992), is expected to cause increased catalytic activity. 
On the other hand, we expect to see decreased catalytic activity by expressing 
the dominant-negative, regulatory subunit (R*), because of its inability to bind 
cAMP and subsequently, constitutive inhibition of the catalytic subunit (personal 
communication with Daniel Kalderon).  
We reproduced the anterior patterning defects reported for Pka-R1 
mutants. However, UAS/GAL4-driven expression of Pka-C* in the ovary caused 
only minor patterning defects in progeny embryos, and the defects were of a 
different type from that seen with the Pka-R1 mutant. Testing three different 
UAS-Pka-C* lines and using the matα4-GAL-VP16 driver, only one produced any 
bicaudal embryos, and even then only at a very low frequency (<1%). On the 
other hand, when PKA activity was decreased in the ovary by expressing UAS-
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Pka-R*, the majority of progeny embryos (98-100%) did not develop cuticles (see 
Table 3.1 for phenotypic analysis and Fig 3.1 for representative images).   
It is not surprising that altering PKA activity would disrupt embryonic 
development, as PKA has roles in oogenesis in addition to its role in osk 
regulation, such as maintenance of nurse cell boundaries and microtubule 
reorganization in the oocyte (Lane and Kalderon, 1994; Lane and Kalderon, 
1995). Why the Pka-R1 mutant and enhanced PKA activity from Pka-C* 
expression have such different effects is not clear, although it seems likely that 
UAS-Pka-C* expression does not dramatically enhance PKA activity.  
We next wanted to see if altering PKA activity resulted in a change in Bru 
phosphorylation. To detect Bru phosphorylation, the conventional approach of 
testing for phosphatase-dependent changes in electrophoretic mobility of the 
protein was used. In phosphatase-treated, wild-type ovary extract, Bru appeared 
by Western-blot analysis as a major band. When ovary extract was treated with 
phosphatase inhibitors, a faint lower-mobility band above the major Bru band 
was apparent. In Pka-R1-mutant ovary extract, however, there is no dramatic 
change in the amount of the phosphoisoform although for this set of samples, a 
small increase is evident (Fig 3.2A; compare lanes 2 and 4).  
Bru phosphorylation was further analyzed by the phosphate-affinity SDS-
PAGE with the acrylamide-pendant Phos-tag, which separates different 
phosphoprotein isoforms. Using this approach, multiple different phosphorylated 
species could be detected in both wild type and Pka-R1 mutant. When wild-type 
ovary extract is treated with phosphatase alone, a major Bru band and two upper 
bands, of which one more distinct and running higher than the other, are seen. 
When inhibitors are also present, there is a visible smudge consisting of multiple 
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bands above the major Bru band. Again, there seems to be a slight increase of 
the phosphoisoforms in Pka-R1-mutant extract, but no significant increase overall 
(Fig 3.2B; compare lanes 1 and 3).  
To make a more extensive comparison, ovary extracts from Pka-R1 
mothers were made on five different days, but we did not see a consistent 
change in phosphorylation from the wild-type control (Fig 3.2C).  
UAS/GAL4 expression of the dominant-negative, regulatory (Pka-R*) 
subunit also did not cause a significant change in the amount of the 
phosphoisoforms. However, a small increase in abundance of the lower-mobility 
band was visible in Pka-C* compared to Pka-R* ovaries across different lines 
tested (Fig 3.2D). Although the levels were more consistently higher with the 
UAS-Pka-C* lines, this could be due to random variation in samples, just as 
observed for the Pka-R1 mutant flies. Alternatively, loss of PKA activity may 
weakly destabilize Bru.  
The failure to detect any consistent change in Bru phosphorylation may be 
because only a small fraction of Bru is phosphorylatable by PKA or because an 
intermediate kinase activated by PKA is rate-limiting (see Discussion).  
 
Increasing PKA activity leads to a minor change in Bruno-dependent 
translational repression 
Translational regulation of osk mRNA is complex. Multiple proteins are 
implicated in repression, and multiple proteins are implicated in activation. To 
focus specifically on Bru-dependent control of osk mRNA translation, we used 
osk1-173::GFP-AB reporter mRNAs (Fig 3.3E) that display two regulatory 
features: Bru-dependent repression throughout the nurse cells and oocyte; and 
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stage-dependent release from repression in the oocyte. The latter effect is most 
dramatic for posterior-specific release from repression at stage 9, as described in 
Chapter 2, but there is also an overall increase in fluorescence throughout the 
oocyte beginning at stage 7/8. The osk1-173::GFP-AB reporter mRNAs include 
an osk 5' region, which encodes an anchoring domain (Vanzo and Ephrussi, 
2002) and serves to restrict movement of the protein (and thus reveals where it is 
translated), and the osk 3' UTR AB region, which contains Bru binding sites and 
mediates Bru-dependent translational repression (Kim-Ha et al., 1995; Reveal et 
al., 2011).  
In the presence of normal PKA activity, Osk1-173::GFP expression was 
slightly enriched in the oocyte from as early as stage 8 (Fig 3.3A) and formed a 
gradient emanating from the posterior at stage 9 (see Chapter 2). When Pka-C* 
was coexpressed with the osk1-173::GFP-AB, no substantial change in the 
posterior gradient of Osk1-173::GFP was detected. However, the earlier, more 
uniform expression of Osk1-173::GFP throughout the oocyte was slightly altered. 
Most stage 8 egg chambers (80%) normally show this pattern, and the frequency 
increased to 97% when Pka-C* was expressed. To determine if this effect 
involves Bru, the experiment was also performed with the osk1-173::GFP-AB 
BRE-, which has mutations in the BREs that largely eliminate Bru-dependent 
repression. In the absence of repression by Bru, the osk1-173::GFP-AB BRE- 
mRNA produces Osk1-173::GFP throughout the nurse cells and oocyte. When 
Pka-C* is coexpressed with the reporter, no consistent change in the Osk1-
173::GFP level was detected. This suggests that the effect of Pka-C* expression 
on the osk1-173::GFP-AB mRNA is mediated by action of PKA on Bru, or on 
some other factor involved in Bru-dependent translational repression. However, 
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the effect is weak, other evidence suggests that this transgene may not have 
much effect on PKA activity, and thus the significance of this result is uncertain. 
 
DISCUSSION 
Regulation of PKA by PKA-R1 is required for oskar regulation and correct 
body patterning  
Strong Pka-R1 mutants have anteroposterior patterning defects, and the 
Pka-R118304 hemizygous egg chambers display premature and ectopic Osk 
expression and an overall increase in the Osk protein level, but the osk RNA 
level and localization are normal. The bicaudal phenotype of the Pka-R1 mutants 
was fully suppressed by either reducing the dosage of DC0 (Pka-C1) or germline 
expression of the RA isoform of Pka-R1, suggesting the patterning defect is 
caused by excess catalytic activity (Yoshida et al., 2004).  
PKA activity may regulate either translational activation or Osk protein 
stability. In this regard, phosphorylation of Osk or a regulator of osk would 
promote its translation or stability. Bru directly binds osk mRNA and represses 
translation (Kim-Ha et al., 1995; Lie and Macdonald, 1999; Castagnetti et al., 
2000), and is phosphorylated in vivo. Moreover, PKA phosphorylates Bru in vitro 
(see Chapter 2). Therefore phosphorylation of Bru could be a mechanism of 
depression of osk translation at the posterior of the oocyte. However, mutating 
the candidate sites of PKA phosphorylation in Bru did not result in any patterning 
defects, leaving open additional substrate possibilities.  
It is also possible that Osk protein may be stabilized, directly or indirectly 
by PKA-mediated phosphorylation. Osk is destabilized by Par-1/GSK-3 
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phosphorylation and subsequent E3-ubiquitin-ligase-mediated targeting to the 
proteasome (Morais-de-Sá et al., 2013). PKA could stabilize Osk via direct 
phosphorylation or by counteracting Par-1/GSK-3 pathway that phosphorylates 
and degrades Osk.  
Both R1 and C1 subunits of PKA are enriched on the germ cell 
membranes (Lane and Kalderon, 1995; Yoshida et al., 2004), likely by interaction 
of PKA-R1 with an A kinase anchoring protein (AKAP) that regulates spatial 
distribution of the PKA holoenzyme (Pidoux and Tasken, 2010; Wong and Scott, 
2004). Moreover, PKA activity is required in the germline for reorganization of the 
microtubule polarity and correct localization of Kin::β-gal, a microtubule plus-end 
marker, at the posterior of the oocyte (Lane and Kalderon, 1994). Hence PKA 
activity is required just before osk mRNA is localized, and may colocalize and 
coincide with Osk expression. Therefore, PKA may transduce a signal from the 
posterior follicle cells for oocyte polarity, and this local activation of PKA may be 
responsible for localized expression of Osk.  
 
Does PKA phosphorylate Bruno? 
We did not see a dramatic change in Bru phosphorylation in response to 
increased PKA catalytic activity. Pka-R1E1 and Pka-R118304 are both strong loss-
of-function alleles of Pka-R1, and embryos from Pka-R1E1/Pka-R118304 mothers 
have strong patterning defects (Yoshida et al., 2004). Yet there was no 
consistent detectable increase of Bru phosphorylation in the Pka-R1E1/Pka-
R118304 mutant when the total amount of Bru protein is comparable between the 
wild type and mutant. Similarly, there was no consistent detectable change in Bru 
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phosphorylation for transgenic flies expressing a constitutively active catalytic 
subunit (C*). One issue with these studies is that Bru appears to be 
phosphorylated at multiple positions, as detected by altered mobility of Bru in 
denaturing gel electrophoresis. However, not all phosphorylations will lead to a 
change in mobility, and the phosphomimetic mutants characterized here are of 
this type. Therefore, the failure to detect changes in Bru phosphorylation by the 
mobility assay does not reveal whether PKA phosphorylates Bru in vivo at the 
same amino acids it phosphorylates in vitro. 
A more revealing indication of whether PKA phosphorylates Bru in vivo 
might come from phenotypic assays. When this work was initiated, a working 
hypothesis was that posterior-specific phosphorylation of Bru by PKA could be 
responsible for changing Bru from a repressor to an activator of translation. This 
would be consistent with the observed effect of excess PKA activity on embryonic 
body patterning. However, the results of Chapter 2 suggest that phosphorylation 
of Bru by PKA promotes its repressive activity, exactly the opposite of what was 
hypothesized. Based on these results, the effect of the Pka-R1 mutant on Osk 
expression would likely occur by an effect on a different target. Because kinases 
can have many targets, this does not rule out action by PKA on Bru. It would be 
interesting to see how reduction of PKA activity affects body patterning, and 
whether the results are consistent with the model for PKA action on Bru from 
Chapter 2. However, a majority of embryos from Pka-R*-expressing mothers do 
not develop to a point of developing cuticles. Likewise, females heterozygous for 
a strong and a weak DC0 allele fail to lay eggs (Lane and Kalderon, 1993; Lane 
and Kalderon, 1994). 
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Another approach to examine phenotypes involves use of the osk1-
173::GFP-AB reporter, which encodes an anchored protein (to reveal where it is 
translated) and includes the osk 3' UTR AB region with its multiple Bru binding 
sites for repression (Kim-Ha et al., 1995; Reveal et al., 2011). This allows 
repression to be predominantly or exclusively dependent on Bru binding to the 
AB region and may be more sensitive to any defect in repression than an mRNA 
with the entire osk 3ʼ UTR bound by several other proteins. In addition, this 
reporter displays posterior Osk::GFP expression, due to either local inhibition of 
Bru repression or shift of Bru from a repressor to an activator. 
We saw a very small increase in the proportion of stage 8/9 egg chambers 
expressing the oocyte Osk1-173::GFP when PKA activity was elevated using the 
UAS-Pka-C* approach. Interpretation of this result is not straightforward, given 
other indications that this transgene does not reproduce the effect of the Pka-R1 
mutant. It would be worthwhile to express the osk1-173::GFP-AB reporter in the 
Pka-R1-mutant background to more definitively test the effect of increasing the 
catalytic activity on Bru-dependent translational regulation. Similarly, it would be 
useful to test the effect of reducing PKA activity with the UAS-Pka-R* transgene.      
 
MATERIALS AND METHODS 
Flies and Transgenes 
w1118 flies were used as the wild type. Pka-R1 flies used were 
transheterozygous for Pka-R1E1 and Pka-R118304, which are strong loss-of-
function alleles identified in genetic screens for maternal-effect mutations in 
anteroposterior patterning of the embryo (Yoshida et al., 2004). Transgenic fly 
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stocks were established by standard methods. Expression of the UAS 
transgenes was driven by the matα4-GAL-VP16 driver (Martin and St. Johnston, 
2003).  
The P[UAS-osk1-173::GFP-AB] transgene was generated by Ginny Pai. 
The P[UAS-Pka-R*] transgene was generated by inserting, into pUASp (Rorth, 
1998) using the same restriction sites, the Asp718-XbaI fragment (from p8931 or 
BDK2 from Daniel Kalderon), which has the full-length Pka-R1 coding sequence, 
with mutations in each of the two cAMP-binding sites as well as a duplication of 
the first three amino acids as a cloning artifact. The P[UAS-Pka-C*] transgene 
was generated by inserting, into pUASp using the same restriction sites, the NotI-
XbaI fragment (from p8928 from Daniel Kalderon), which has the full-length 
mouse Pka-C coding sequence with H87Q and W196R mutations (Orellana and 
McKnight, 1992), as well as the 3' UTR from the human growth hormone (hGH) 
gene (DeNoto et al., 1981). The point mutations render PKA-C* insensitive to 
regulation by PKA-R (Orellana and McKnight, 1992).  
 
Detection of Phosphorylated Bruno in the Ovary 
Ovaries from young females, fed on yeast for 3-4 days, were dissected 
and extract was prepared as previously described (Kim-Ha et al., 1995) in ice-
cold lysis buffer (50mM Hepes pH7.9, 150mM KCl, and 1% IGEPAL-CA-630) 
supplemented with Complete, Mini, EDTA-free protease inhibitor cocktail tablet 
(Roche). Reactions (20μl) contained 10-15μg of ovary extract in phosphatase 
buffer (50mM Hepes pH7.9, 100mM NaCl, 10mM MgCl2, and 1mM DTT), and 
where indicated, one or more of the following components were added: 1-2 units 
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of alkaline phosphatase (calf intestinal, NEB), 1.6M beta-glycero phosphate, and 
40mM sodium vanadate. Reactions were incubated at 30°C for 1 hr and 
terminated by addition of 3X SDS loading buffer. Proteins were separated by 
SDS-PAGE and analyzed by Western blot.  
For the phosphate-affinity SDS-PAGE using acrylamide-pendant Phos-tag 
(WAKO), 50μM Phos-tag and 200μM MnCl2 were added to both stacking and 
separating gels in solution.  
Mouse anti-Bru antibody (from Nakamura lab) diluted at 1:8000 and 
mouse anti-αTubulin antibody (Sigma) diluted at 1:1000 were used for Western 
blot, together with the alkaline phosphatase-conjugated goat anti-mouse antibody 
(Applied Biosystems) diluted at 1:5000.  
 
Whole-Mount Ovary Staining 
For detection of GFP in situ, ovaries from young females fed on yeast for 
3-4 days were dissected into PBS at room temperature and fixed in 4% 
formaldehyde in PBS for 20 min with gentle mixing. The ovaries were then 
washed for 30 min in four changes of PBT (PBS plus 0.1% Triton X-100) and 
blocked for 2 hr in four changes of PBT containing 5% goat serum. Nuclei were 
counterstained with TO-PRO-3 Iodide (642/661, Invitrogen) diluted 1:1000 in PBT 
containing 1% goat serum for 1 hr at room temperature. Egg chambers were 
washed several times over 3 hr in PBT and then mounted in Vectashield (Vector 
Labs). Microscopy of all samples made use of a Leica TCS-SP laser scanning 
confocal microscope.  
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Phenotypic Analysis 
Embryos were collected from young females in small population cages, 
aged for at least 24 hr, and cuticles were prepared and mounted for examination, 
as described (Wieschaus and Nüsslein-Volhard, 1986).  
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 FIGURES 
 
Figure 3.1. Examples of embryonic 
phenotypes of Pka mutant and 
transgenics 
Each panel shows a cuticle of an embryo 
from either Pka-R1-mutant mothers or 
mothers expressing one copy of the Pka 
transgenes. (A) is phenotypically wild type 
having eight abdominal denticle belts and a 
normal head at the anterior (left) and tail at 
the posterior (right). (B) is a bicaudal 
embryo that occurs with increasing or ectopic Osk patterning activity and lacks a 
head at the expense of a duplicated abdomen and tail. It is the most commonly 
observed phenotype of embryos from Pka-R1 mothers. Note that typically, high 
level of Osk overexpression produces bicaudal embryos with many fewer 
abdominal segments remaining than what is shown here. This cuticle pattern with 
multiple duplicated abdominal segments suggests that it is more than simply 
overexpression of Osk that is responsible. (C) is an embryo that did not develop 
far enough to produce a cuticle and is the most commonly observed phenotype 
of embryos from Pka-R* mothers.  
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C
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 Figure 3.2. Bru phosphorylation in response to change in PKA activity 
 (A) Western blot of wild-type and Pka-R1-mutant ovary extract after incubation 
with Calf intestine alkaline phosphatase, either alone or together with 
phosphatase inhibitors, as indicated above. Proteins were detected using anti-
Bru (top) or anti-Tubulin (bottom) antibody. Inhibitors used were sodium vanadate 
and beta-glycero phosphate, which are competitive inhibitors of alkaline 
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 121 
phosphatase. Pka-R1 mutants used are transheterozygous for two strong, loss-
of-function alleles, Pka-R1E1 and Pka-R118304.  
 (B) Wild-type and Pka-R1-mutant ovary extract incubated with Calf intestine 
alkaline phosphatase, either alone or together with phosphatase inhibitors, as 
indicated above, was run on phosphate-affinity SDS-PAGE using acrylamide-
pendant Phos-tag that separates different phosphoprotein isoforms, followed by 
Western blot to detect proteins using anti-Bru antibody. Inhibitors used are as 
noted in (A).  
 (C) Ovary extract from Pka-R1 mutants was prepared on five different days and 
incubated with, along with wild-type ovary extract, Calf intestine alkaline 
phosphatase, either alone or together with phosphatase inhibitors, as indicated 
above. Proteins were detected by Western blot using anti-Bru (top) or anti-
Tubulin (bottom) antibody. Inhibitors used are as noted in (A).  
 (D) Ovary extract from multiple lines of UAS-Pka-R*- or UAS-Pka-C*-expressing 
flies, as indicated above, was prepared along with wild-type ovary extract. 
Proteins were detected by Western blot using anti-Bru (top) or anti-Tubulin 
(bottom) antibody.  
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Figure 3.3. PKA-dependent change in the osk::GFP reporter expression 
 (A-D, Aʼ-Dʼ) show egg chambers expressing the osk::GFP reporter containing 
the osk 5ʼ region and either wild-type (A-B, Aʼ-Bʼ) or mutant (C-D, Cʼ-Dʼ) AB 
region. (B, Bʼ, D, Dʼ) also express the Pka-C* transgene. All have a single copy of 
each of the transgenes. (Aʼ-Dʼ) show GFP in green and nuclei in red. All samples 
were fixed in parallel and imaged together, and each pair of images in 
comparison was taken under the same settings. The GFP signal in (A and B) 
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was elevated to (Aʼʼ and Bʼʼ) to highlight the oocyte enrichment. Expression of the 
UAS transgenes was driven by the matα4-GAL-VP16 driver (Martin and St. 
Johnston, 2003).  
 (E) A schematic diagram of the UAS-osk::GFP-AB reporter. The large rectangle 
comprises a part of the osk coding sequence including two start codons and up 
to T173 and a full GFP coding sequence as labeled. The osk 3' UTR AB region, 
which contains the BREs, is depicted as the small rectangle. The thick black line 
includes the 15nt 5ʼ UTR common to both Osk isoforms and 5ʼ UTR specific for 
the short isoform. The thick gray line is the 0.4kb K10 3ʼ UTR fragment, part of 
the pUASp vector sequence in gray (Rorth, 1998).  
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TABLES 
 
Table 3.1. Embryonic development of Pka mutant and transgenics 
a E1 and 18304 are strong loss-of-function alleles of the Pka-R1 gene encoding 
the regulatory subunit of PKA. * denotes a gain-of-function mutation in the 
catalytic or regulatory subunit of PKA. w1118 was used as a wild-type control. 
Expression of the UAS transgenes was driven by the matα4-GAL-VP16 driver 
(Martin and St. Johnston, 2003).  
b Wild-type embryonic cuticles have eight abdominal denticle belts and a normal 
head. This category includes a very small percentage of embryos missing a 
single abdominal segment, which is common for embryos from females with the 
matα4-GAL-VP16 driver. Embryos with head defects do not have head 
structures. Bicaudal embryos lack head and anterior abdominal segments at the 
expense of duplicated posterior segments. See Figure 3.1 for a representative 
image for each phenotype.  
 
 
Table  1.  Embryonic  development  of  Pka  mutant  and  transgenics
bCuticular  Phenotype  (%)
n
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